FR3118579A1 - COMPOSITION FOR CARE OF KERATINOUS MATERIALS - Google Patents
COMPOSITION FOR CARE OF KERATINOUS MATERIALS Download PDFInfo
- Publication number
- FR3118579A1 FR3118579A1 FR2101420A FR2101420A FR3118579A1 FR 3118579 A1 FR3118579 A1 FR 3118579A1 FR 2101420 A FR2101420 A FR 2101420A FR 2101420 A FR2101420 A FR 2101420A FR 3118579 A1 FR3118579 A1 FR 3118579A1
- Authority
- FR
- France
- Prior art keywords
- acid
- composition
- composition according
- polyols
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 93
- 239000000463 material Substances 0.000 title claims abstract description 20
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 50
- 229920005862 polyol Polymers 0.000 claims abstract description 40
- 150000003077 polyols Chemical class 0.000 claims abstract description 40
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 28
- 230000001588 bifunctional effect Effects 0.000 claims abstract description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 239000007844 bleaching agent Substances 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 49
- 230000003078 antioxidant effect Effects 0.000 claims description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 26
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 229930003935 flavonoid Natural products 0.000 claims description 18
- 235000017173 flavonoids Nutrition 0.000 claims description 18
- 150000002215 flavonoids Chemical class 0.000 claims description 16
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 12
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 12
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 9
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 235000021466 carotenoid Nutrition 0.000 claims description 8
- 150000001747 carotenoids Chemical class 0.000 claims description 8
- 235000001785 ferulic acid Nutrition 0.000 claims description 8
- 229940114124 ferulic acid Drugs 0.000 claims description 8
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 8
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 claims description 6
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 claims description 6
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 5
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 4
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 4
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims description 4
- 229920002079 Ellagic acid Polymers 0.000 claims description 4
- 229960002852 ellagic acid Drugs 0.000 claims description 4
- 235000004132 ellagic acid Nutrition 0.000 claims description 4
- 229940074391 gallic acid Drugs 0.000 claims description 4
- 235000004515 gallic acid Nutrition 0.000 claims description 4
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 4
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 3
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 claims description 3
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 claims description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 3
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 claims description 3
- 235000004883 caffeic acid Nutrition 0.000 claims description 3
- 229940074360 caffeic acid Drugs 0.000 claims description 3
- 235000005513 chalcones Nutrition 0.000 claims description 3
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 claims description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 3
- 229940074393 chlorogenic acid Drugs 0.000 claims description 3
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 3
- 235000006193 cichoric acid Nutrition 0.000 claims description 3
- 229930016920 cichoric acid Natural products 0.000 claims description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 3
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 3
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 claims description 3
- 150000001261 hydroxy acids Chemical class 0.000 claims description 3
- 235000017807 phytochemicals Nutrition 0.000 claims description 3
- 229930000223 plant secondary metabolite Natural products 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 claims description 3
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 claims description 3
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 claims description 3
- 150000003436 stilbenoids Chemical class 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- 229930153442 Curcuminoid Natural products 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 229940051250 hexylene glycol Drugs 0.000 claims description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 244000000231 Sesamum indicum Species 0.000 description 10
- 235000003434 Sesamum indicum Nutrition 0.000 description 10
- -1 flavonoid compounds Chemical class 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 9
- 235000010208 anthocyanin Nutrition 0.000 description 9
- 239000004410 anthocyanin Substances 0.000 description 9
- 229930002877 anthocyanin Natural products 0.000 description 9
- 150000004636 anthocyanins Chemical class 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 229920002125 Sokalan® Polymers 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- LBTVHXHERHESKG-UHFFFAOYSA-N tetrahydrocurcumin Chemical compound C1=C(O)C(OC)=CC(CCC(=O)CC(=O)CCC=2C=C(OC)C(O)=CC=2)=C1 LBTVHXHERHESKG-UHFFFAOYSA-N 0.000 description 8
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 239000011668 ascorbic acid Substances 0.000 description 7
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 7
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 7
- 229930013686 lignan Natural products 0.000 description 7
- 235000009408 lignans Nutrition 0.000 description 7
- 150000005692 lignans Chemical class 0.000 description 7
- 229960005070 ascorbic acid Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 235000011957 flavonols Nutrition 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000003349 gelling agent Substances 0.000 description 4
- 229930015704 phenylpropanoid Natural products 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 4
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 3
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 3
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000012754 curcumin Nutrition 0.000 description 3
- 239000004148 curcumin Substances 0.000 description 3
- 229940109262 curcumin Drugs 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 3
- 150000007946 flavonol Chemical class 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 235000008777 kaempferol Nutrition 0.000 description 3
- 235000012680 lutein Nutrition 0.000 description 3
- 239000001656 lutein Substances 0.000 description 3
- 229960005375 lutein Drugs 0.000 description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 3
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 235000021283 resveratrol Nutrition 0.000 description 3
- 229940016667 resveratrol Drugs 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 3
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 description 2
- RSYUFYQTACJFML-UKRRQHHQSA-N (-)-epiafzelechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C=C1 RSYUFYQTACJFML-UKRRQHHQSA-N 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 2
- YEDFEBOUHSBQBT-UHFFFAOYSA-N 2,3-dihydroflavon-3-ol Chemical compound O1C2=CC=CC=C2C(=O)C(O)C1C1=CC=CC=C1 YEDFEBOUHSBQBT-UHFFFAOYSA-N 0.000 description 2
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- YTMFRMLVZQOBDR-UHFFFAOYSA-N 2-phenyl-3,4-dihydro-2h-chromen-4-ol Chemical compound O1C2=CC=CC=C2C(O)CC1C1=CC=CC=C1 YTMFRMLVZQOBDR-UHFFFAOYSA-N 0.000 description 2
- HMUJXQRRKBLVOO-AWEZNQCLSA-N 4'-methoxy-5,7-dihydroxyflavanone Chemical compound C1=CC(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 HMUJXQRRKBLVOO-AWEZNQCLSA-N 0.000 description 2
- VXIXUWQIVKSKSA-UHFFFAOYSA-N 4-hydroxycoumarin Chemical compound C1=CC=CC2=C1OC(=O)C=C2O VXIXUWQIVKSKSA-UHFFFAOYSA-N 0.000 description 2
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 2
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 2
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 2
- CCJBNIRSVUKABH-UHFFFAOYSA-N Natsudaidain Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(O)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 CCJBNIRSVUKABH-UHFFFAOYSA-N 0.000 description 2
- 229930012538 Paclitaxel Natural products 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- ZFAHNWWNDFHPOH-YFKPBYRVSA-N S-allylcysteine Chemical compound OC(=O)[C@@H](N)CSCC=C ZFAHNWWNDFHPOH-YFKPBYRVSA-N 0.000 description 2
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 2
- CZNLTCTYLMYLHL-UHFFFAOYSA-N [6]-Paradol Chemical compound CCCCCCCC(=O)CCC1=CC=C(O)C(OC)=C1 CZNLTCTYLMYLHL-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 2
- 229940015301 baicalein Drugs 0.000 description 2
- OBIUGMGQVQMVSK-UHFFFAOYSA-N barbigerone Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=CC=C2C1=O OBIUGMGQVQMVSK-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 2
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N caprylic acid monoglyceride Natural products CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 235000007240 daidzein Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- DOBMPNYZJYQDGZ-UHFFFAOYSA-N dicoumarol Chemical compound C1=CC=CC2=C1OC(=O)C(CC=1C(OC3=CC=CC=C3C=1O)=O)=C2O DOBMPNYZJYQDGZ-UHFFFAOYSA-N 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229930182497 flavan-3-ol Natural products 0.000 description 2
- 229930003949 flavanone Natural products 0.000 description 2
- 150000002208 flavanones Chemical class 0.000 description 2
- 235000011981 flavanones Nutrition 0.000 description 2
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 description 2
- VCCRNZQBSJXYJD-UHFFFAOYSA-N galangin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1 VCCRNZQBSJXYJD-UHFFFAOYSA-N 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 description 2
- 229960004135 idebenone Drugs 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- 230000037306 mature skin Effects 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 2
- 235000007743 myricetin Nutrition 0.000 description 2
- 229940116852 myricetin Drugs 0.000 description 2
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 229960001592 paclitaxel Drugs 0.000 description 2
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 2
- 125000001474 phenylpropanoid group Chemical group 0.000 description 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- GMPPKSLKMRADRM-SWLSCSKDSA-N robinetinidol Chemical compound C1([C@H]2OC3=CC(O)=CC=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 GMPPKSLKMRADRM-SWLSCSKDSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
- KEQHJBNSCLWCAE-UHFFFAOYSA-N thymoquinone Chemical compound CC(C)C1=CC(=O)C(C)=CC1=O KEQHJBNSCLWCAE-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 description 1
- NLAWPKPYBMEWIR-SKYQDXIQSA-N (2S)-poncirin Chemical compound C1=CC(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 NLAWPKPYBMEWIR-SKYQDXIQSA-N 0.000 description 1
- FSYDWKPCKNCRDI-OLZOCXBDSA-N (2S,4R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-4,5,7-triol Chemical compound O[C@@H]1C[C@H](Oc2cc(O)cc(O)c12)c1ccc(O)c(O)c1 FSYDWKPCKNCRDI-OLZOCXBDSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- FDHNLHLOJLLXDH-JIYHLSBYSA-N (e)-3-(3-hydroxy-4-methoxyphenyl)-1-[2-hydroxy-6-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]prop-2-en-1-one Chemical compound C1=C(O)C(OC)=CC=C1\C=C\C(=O)C(C(=C1)OC)=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 FDHNLHLOJLLXDH-JIYHLSBYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- VFHSXDLCCBWTTJ-UHFFFAOYSA-N 1-(2,4-dimethoxy-6-hydroxyphenyl)-3-(4-hydroxyphenyl)-propan-1-one Natural products COC1=CC(OC)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 VFHSXDLCCBWTTJ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- OPLCSTZDXXUYDU-UHFFFAOYSA-N 2,4-dimethyl-6-tert-butylphenol Chemical compound CC1=CC(C)=C(O)C(C(C)(C)C)=C1 OPLCSTZDXXUYDU-UHFFFAOYSA-N 0.000 description 1
- DKCPKDPYUFEZCP-UHFFFAOYSA-N 2,6-di-tert-butylphenol Chemical compound CC(C)(C)C1=CC=CC(C(C)(C)C)=C1O DKCPKDPYUFEZCP-UHFFFAOYSA-N 0.000 description 1
- FYSMTINDJSASRR-UFGFRKJLSA-N 2-(3,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one Chemical compound O([C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)C=1C(=O)C=2C(OC)=CC(O)=CC=2OC=1C1=CC=C(O)C(O)=C1 FYSMTINDJSASRR-UFGFRKJLSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- VZBPTZZTCBNBOZ-VJXVFPJBSA-N 3-(4-hydroxyphenyl)-1-[2,4,6-trihydroxy-3-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl]propan-1-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C(C(=O)CCC=2C=CC(O)=CC=2)=C1O VZBPTZZTCBNBOZ-VJXVFPJBSA-N 0.000 description 1
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 206010068388 Actinic elastosis Diseases 0.000 description 1
- 240000001606 Adenanthera pavonina Species 0.000 description 1
- 235000011470 Adenanthera pavonina Nutrition 0.000 description 1
- UNHHWEHQUUGKEE-MLLLWRCASA-N Amurensin Chemical compound C1=C(O)C(C(C(O)=C(O2)C=3C=CC(O)=CC=3)=O)=C2C(CCC(C)(O)C)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UNHHWEHQUUGKEE-MLLLWRCASA-N 0.000 description 1
- HDQHRTXBXYQUNW-CABCVRRESA-N Amurensine Natural products O(C)c1c(O)cc2[C@H]3c4c(cc5OCOc5c4)C[C@H](N(C)C3)c2c1 HDQHRTXBXYQUNW-CABCVRRESA-N 0.000 description 1
- RPKUCYSGAXIESU-CHWSQXEVSA-N Apiferol Natural products O[C@H]1c2c(O)cc(O)cc2O[C@@H](c2ccc(O)cc2)C1 RPKUCYSGAXIESU-CHWSQXEVSA-N 0.000 description 1
- RPKUCYSGAXIESU-UHFFFAOYSA-N Apiforol Natural products O1C2=CC(O)=CC(O)=C2C(O)CC1C1=CC=C(O)C=C1 RPKUCYSGAXIESU-UHFFFAOYSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- VGONRPRFJVEJKB-UHFFFAOYSA-O Aurantinidin Chemical compound C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=C(O)C(O)=C2 VGONRPRFJVEJKB-UHFFFAOYSA-O 0.000 description 1
- RSDDHGSKLOSQFK-PTNGSMBKSA-N Auraptene Natural products C1=CC(=O)OC2=CC(OC\C=C(C)/CCC=C(C)C)=CC=C21 RSDDHGSKLOSQFK-PTNGSMBKSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- HGJXAVROWQLCTP-YABCKIEDSA-N Chebulagic acid Chemical compound O([C@H]1[C@H]2[C@H]3OC(=O)C4=CC(O)=C(O)C(O)=C4C4=C(O)C(O)=C(O)C=C4C(=O)OC[C@@H](O1)[C@H]3OC(=O)[C@@H](CC(O)=O)[C@@H]1[C@@H](C(OC=3C(O)=C(O)C=C(C1=3)C(=O)O2)=O)O)C(=O)C1=CC(O)=C(O)C(O)=C1 HGJXAVROWQLCTP-YABCKIEDSA-N 0.000 description 1
- 229920002052 Chebulagic acid Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- HDOMLWFFJSLFBI-UHFFFAOYSA-N Eriocitrin Natural products CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(Oc4c3)c5ccc(OC6OC(COC7OC(C)C(O)C(O)C7O)C(O)C(O)C6O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O HDOMLWFFJSLFBI-UHFFFAOYSA-N 0.000 description 1
- JMVXRLMOIOTWSB-PFZAOBAISA-N Eriodictin Chemical compound C[C@@H]1O[C@@H](Oc2cc(O)c3C(=O)C[C@H](Oc3c2)c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O JMVXRLMOIOTWSB-PFZAOBAISA-N 0.000 description 1
- JMVXRLMOIOTWSB-UYVJFODRSA-N Eriodictin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1)c1cc(O)c2C(=O)C[C@H](c3cc(O)c(O)cc3)Oc2c1 JMVXRLMOIOTWSB-UYVJFODRSA-N 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical class CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 239000001183 FEMA 4495 Substances 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 229920000296 Glucogallin Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 101001051272 Homo sapiens Layilin Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000001549 Ipomoea eriocarpa Species 0.000 description 1
- 235000005146 Ipomoea eriocarpa Nutrition 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 1
- YKGCBLWILMDSAV-GOSISDBHSA-N Isoxanthohumol Natural products O(C)c1c2C(=O)C[C@H](c3ccc(O)cc3)Oc2c(C/C=C(\C)/C)c(O)c1 YKGCBLWILMDSAV-GOSISDBHSA-N 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- 102100024621 Layilin Human genes 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- FSYDWKPCKNCRDI-STQMWFEESA-N Luteoforol Natural products O[C@@H]1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)cc2)C1 FSYDWKPCKNCRDI-STQMWFEESA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- XGEYXJDOVMEJNG-HTFDPZBKSA-N Marein Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1O)O)=CC=C1C(=O)\C=C\C1=CC=C(O)C(O)=C1 XGEYXJDOVMEJNG-HTFDPZBKSA-N 0.000 description 1
- XGEYXJDOVMEJNG-CMWLGVBASA-N Marein Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1O)O)=CC=C1C(=O)C=CC1=CC=C(O)C(O)=C1 XGEYXJDOVMEJNG-CMWLGVBASA-N 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- TXULLYMENMRLHL-UHFFFAOYSA-N Mesquitol Natural products OC1CC2=CC=C(O)C(O)=C2OC1C1=CC=C(O)C(O)=C1 TXULLYMENMRLHL-UHFFFAOYSA-N 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 235000016392 Myrciaria paraensis Nutrition 0.000 description 1
- 244000002791 Myrciaria paraensis Species 0.000 description 1
- MVAWJSIDNICKHF-UHFFFAOYSA-N N-acetylserotonin Chemical compound C1=C(O)C=C2C(CCNC(=O)C)=CNC2=C1 MVAWJSIDNICKHF-UHFFFAOYSA-N 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- LUCQSVLCPJUJRN-UHVRHXOTSA-N Naringerin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1)c1cc(O)c2C(=O)C[C@H](c3ccc(O)cc3)Oc2c1 LUCQSVLCPJUJRN-UHVRHXOTSA-N 0.000 description 1
- CWBZAESOUBENAP-QVNVHUMTSA-N Naringin dihydrochalcone Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C(O)C(C(=O)CCC=3C=CC(O)=CC=3)=C(O)C=2)O[C@H](CO)[C@@H](O)[C@@H]1O CWBZAESOUBENAP-QVNVHUMTSA-N 0.000 description 1
- VZBPTZZTCBNBOZ-ODJUOBDQSA-N Nothofagin Natural products O=C(CCc1ccc(O)cc1)c1c(O)c([C@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c(O)cc1O VZBPTZZTCBNBOZ-ODJUOBDQSA-N 0.000 description 1
- DBEVFDSIUAOFPU-FWCPWLSYSA-N OC=1C=C(C=C(C=1)O)[C@H]1OC2=C(C([C@@H]1O)=O)C(=C(C(=C2)O)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)O Chemical compound OC=1C=C(C=C(C=1)O)[C@H]1OC2=C(C([C@@H]1O)=O)C(=C(C(=C2)O)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)O DBEVFDSIUAOFPU-FWCPWLSYSA-N 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- NLAWPKPYBMEWIR-VGQRFNKBSA-N Poncirin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C[C@@H](c3ccc(OC)cc3)Oc2c1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 NLAWPKPYBMEWIR-VGQRFNKBSA-N 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical class CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 229920000171 Quercitannic acid Polymers 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- CVBNMWXECPZOLM-UHFFFAOYSA-N Rhamnetin Natural products COc1cc(O)c2C(=O)C(=C(Oc2c1)c3ccc(O)c(O)c3O)O CVBNMWXECPZOLM-UHFFFAOYSA-N 0.000 description 1
- 239000004216 Rhodoxanthin Substances 0.000 description 1
- VWXMLZQUDPCJPL-ZDHAIZATSA-N Rhodoxanthin Chemical compound CC\1=CC(=O)CC(C)(C)C/1=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C1\C(C)=CC(=O)CC1(C)C VWXMLZQUDPCJPL-ZDHAIZATSA-N 0.000 description 1
- VWXMLZQUDPCJPL-XPZLFLLQSA-N Rhodoxanthin Natural products O=C1C=C(C)/C(=C\C=C(/C=C/C=C(\C=C\C=C\C(=C/C=C/C(=C\C=C\2/C(C)=CC(=O)CC/2(C)C)/C)\C)/C)\C)/C(C)(C)C1 VWXMLZQUDPCJPL-XPZLFLLQSA-N 0.000 description 1
- GMPPKSLKMRADRM-UHFFFAOYSA-N Robidanol Natural products OC1CC2=CC=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 GMPPKSLKMRADRM-UHFFFAOYSA-N 0.000 description 1
- PEFASEPMJYRQBW-HKWQTAEVSA-N Robinin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-HKWQTAEVSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- ZFAHNWWNDFHPOH-UHFFFAOYSA-N S-Allyl-L-cystein Natural products OC(=O)C(N)CSCC=C ZFAHNWWNDFHPOH-UHFFFAOYSA-N 0.000 description 1
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 241001092387 Spiraea Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229920000599 Terflavin B Polymers 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- VWXMLZQUDPCJPL-JCFHCUBBSA-N all-trans-Rhodoxanthin Natural products CC(=C/C=C/C(=C/C=C/1C(=CC(=O)CC1(C)C)C)/C)C=CC=CC(=CC=CC(=CC=C2/C(=CC(=O)CC2(C)C)C)C)C VWXMLZQUDPCJPL-JCFHCUBBSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- UNHHWEHQUUGKEE-UHFFFAOYSA-N amurensin Natural products C1=C(O)C(C(C(O)=C(O2)C=3C=CC(O)=CC=3)=O)=C2C(CCC(C)(O)C)=C1OC1OC(CO)C(O)C(O)C1O UNHHWEHQUUGKEE-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 1
- RPKUCYSGAXIESU-ABLWVSNPSA-N apiforol Chemical compound C1([C@@H]2CC(C3=C(O)C=C(O)C=C3O2)O)=CC=C(O)C=C1 RPKUCYSGAXIESU-ABLWVSNPSA-N 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- VCPUQYKWJRESOC-VJXVFPJBSA-N aspalathin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C(C(=O)CCC=2C=C(O)C(O)=CC=2)=C1O VCPUQYKWJRESOC-VJXVFPJBSA-N 0.000 description 1
- VCPUQYKWJRESOC-UHFFFAOYSA-N aspalathine Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C(C(=O)CCC=2C=C(O)C(O)=CC=2)=C1O VCPUQYKWJRESOC-UHFFFAOYSA-N 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 229930015058 aurantinidin Natural products 0.000 description 1
- CNHODYMYYJAOIR-UHFFFAOYSA-N aurapten Natural products CC(CC=CCOc1ccc2C=CC(=O)Oc2c1)C=C(C)C CNHODYMYYJAOIR-UHFFFAOYSA-N 0.000 description 1
- RSDDHGSKLOSQFK-RVDMUPIBSA-N auraptene Chemical compound C1=CC(=O)OC2=CC(OC/C=C(C)/CCC=C(C)C)=CC=C21 RSDDHGSKLOSQFK-RVDMUPIBSA-N 0.000 description 1
- FYSMTINDJSASRR-UHFFFAOYSA-N azalein Natural products O1C(C)C(O)C(O)C(O)C1OC=1C(=O)C=2C(OC)=CC(O)=CC=2OC=1C1=CC=C(O)C(O)=C1 FYSMTINDJSASRR-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- GDVRUDXLQBVIKP-UHFFFAOYSA-N beta-D-glucogallin Natural products OC1C(O)C(O)C(CO)OC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011774 beta-cryptoxanthin Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- JYTVKRNTTALBBZ-UHFFFAOYSA-N bis demethoxycurcumin Natural products C1=CC(O)=CC=C1C=CC(=O)CC(=O)C=CC1=CC=CC(O)=C1 JYTVKRNTTALBBZ-UHFFFAOYSA-N 0.000 description 1
- PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- UGIVASYMZSZAMP-UHFFFAOYSA-N chebulagic acid Natural products OC1C2c3c(OC1=O)c(O)c(O)cc3C(=O)OC4C(OC(=O)c5cc(O)c(O)c(O)c5)OC6COC(=O)c7cc(O)c(O)c(O)c7c8c(O)c(O)c(O)cc8C(=O)OC4C6OC(=O)C2(O)C(=O)O UGIVASYMZSZAMP-UHFFFAOYSA-N 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000002442 collagenase inhibitor Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 description 1
- FUSADYLVRMROPL-UHFFFAOYSA-N demethylxanthohumol Natural products CC(C)=CCC1=C(O)C=C(O)C(C(=O)C=CC=2C=CC(O)=CC=2)=C1O FUSADYLVRMROPL-UHFFFAOYSA-N 0.000 description 1
- YXAKCQIIROBKOP-UHFFFAOYSA-N di-p-hydroxycinnamoylmethane Natural products C=1C=C(O)C=CC=1C=CC(=O)C=C(O)C=CC1=CC=C(O)C=C1 YXAKCQIIROBKOP-UHFFFAOYSA-N 0.000 description 1
- 229960001912 dicoumarol Drugs 0.000 description 1
- KQNGHARGJDXHKF-UHFFFAOYSA-N dihydrotamarixetin Natural products C1=C(O)C(OC)=CC=C1C1C(O)C(=O)C2=C(O)C=C(O)C=C2O1 KQNGHARGJDXHKF-UHFFFAOYSA-N 0.000 description 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 1
- 229960004352 diosmin Drugs 0.000 description 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- QELUYTUMUWHWMC-UHFFFAOYSA-N edaravone Chemical compound O=C1CC(C)=NN1C1=CC=CC=C1 QELUYTUMUWHWMC-UHFFFAOYSA-N 0.000 description 1
- 229950009041 edaravone Drugs 0.000 description 1
- VFZYLYJWCROVLO-UHFFFAOYSA-N ent-Fisetidinol Natural products OC1CC2=CC=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 VFZYLYJWCROVLO-UHFFFAOYSA-N 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- FJSOHLNMRNSYFR-OPDZODGYSA-N epimedoside C Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(C/C=C(\C)/C)c2OC(c3ccc(O)cc3)=C(O)C(=O)c2c(O)c1 FJSOHLNMRNSYFR-OPDZODGYSA-N 0.000 description 1
- ADFCQWZHKCXPAJ-GFCCVEGCSA-N equol Chemical class C1=CC(O)=CC=C1[C@@H]1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-GFCCVEGCSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 229930003487 europinidin Natural products 0.000 description 1
- XJXMPIWHBIOJSH-UHFFFAOYSA-O europinidin Chemical compound OC1=C(O)C(OC)=CC(C=2C(=CC=3C(OC)=CC(O)=CC=3[O+]=2)O)=C1 XJXMPIWHBIOJSH-UHFFFAOYSA-O 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- VFZYLYJWCROVLO-DZGCQCFKSA-N fisetinidol Chemical compound C1([C@H]2OC3=CC(O)=CC=C3C[C@@H]2O)=CC=C(O)C(O)=C1 VFZYLYJWCROVLO-DZGCQCFKSA-N 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 150000005836 flavan-4-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- QKQLSQLKXBHUSO-CMDGGOBGSA-N flavokawain B Chemical compound COC1=CC(OC)=CC(O)=C1C(=O)\C=C\C1=CC=CC=C1 QKQLSQLKXBHUSO-CMDGGOBGSA-N 0.000 description 1
- UXUFMIJZNYXWDX-VMPITWQZSA-N flavokawain C Chemical compound COC1=CC(OC)=CC(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 UXUFMIJZNYXWDX-VMPITWQZSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N flavone Chemical class O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- CIPSYTVGZURWPT-UHFFFAOYSA-N galangin Natural products OC1=C(Oc2cc(O)c(O)cc2C1=O)c3ccccc3 CIPSYTVGZURWPT-UHFFFAOYSA-N 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- KGHSLXLLBHRMML-VKISENBKSA-N glucogallin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](OC)O[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1 KGHSLXLLBHRMML-VKISENBKSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- RHYGXRGFSFQNLC-DZGCQCFKSA-N guibourtinidol Chemical compound C1([C@H]2OC3=CC(O)=CC=C3C[C@@H]2O)=CC=C(O)C=C1 RHYGXRGFSFQNLC-DZGCQCFKSA-N 0.000 description 1
- RHYGXRGFSFQNLC-UHFFFAOYSA-N guibourtinidol Natural products OC1CC2=CC=C(O)C=C2OC1C1=CC=C(O)C=C1 RHYGXRGFSFQNLC-UHFFFAOYSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- LIIALPBMIOVAHH-UHFFFAOYSA-N herniarin Chemical compound C1=CC(=O)OC2=CC(OC)=CC=C21 LIIALPBMIOVAHH-UHFFFAOYSA-N 0.000 description 1
- JHGVLAHJJNKSAW-UHFFFAOYSA-N herniarin Natural products C1CC(=O)OC2=CC(OC)=CC=C21 JHGVLAHJJNKSAW-UHFFFAOYSA-N 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- 235000010209 hesperetin Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- 229940076640 hesperidin methylchalcone Drugs 0.000 description 1
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- DDELFAUOHDSZJL-UHFFFAOYSA-N kaempferol 3-O-rutinoside-7-O-rhamnoside Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C1=O DDELFAUOHDSZJL-UHFFFAOYSA-N 0.000 description 1
- PEFASEPMJYRQBW-UHFFFAOYSA-N kaempferol 7-O-alpha-L-rhamnopyradoside 3-O-beta-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(OC4C(C(O)C(O)C(C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-UHFFFAOYSA-N 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 206010024217 lentigo Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 229930013978 luteolinidin Natural products 0.000 description 1
- GDNIGMNXEKGFIP-UHFFFAOYSA-O luteolinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=CC=1C1=CC=C(O)C(O)=C1 GDNIGMNXEKGFIP-UHFFFAOYSA-O 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 150000008146 mannosides Chemical class 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- TXULLYMENMRLHL-GXTWGEPZSA-N mesquitol Chemical compound C1([C@H]2OC3=C(O)C(O)=CC=C3C[C@@H]2O)=CC=C(O)C(O)=C1 TXULLYMENMRLHL-GXTWGEPZSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 description 1
- KQFUXLQBMQGNRT-UHFFFAOYSA-N pachypodol Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(OC)=C1 KQFUXLQBMQGNRT-UHFFFAOYSA-N 0.000 description 1
- UOJMTSCORVQOHS-UHFFFAOYSA-N pachypodol Natural products COc1cc(ccc1O)C2=C(C)C(=O)c3c(O)cc(C)cc3O2 UOJMTSCORVQOHS-UHFFFAOYSA-N 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229930015717 petunidin Natural products 0.000 description 1
- 235000006384 petunidin Nutrition 0.000 description 1
- QULMBDNPZCFSPR-UHFFFAOYSA-N petunidin chloride Chemical compound [Cl-].OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 QULMBDNPZCFSPR-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 235000003784 poor nutrition Nutrition 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- FYPMFJGVHOHGLL-UHFFFAOYSA-N probucol Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1SC(C)(C)SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FYPMFJGVHOHGLL-UHFFFAOYSA-N 0.000 description 1
- 229960003912 probucol Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical compound [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 description 1
- 229960002026 pyrithione Drugs 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000007845 reactive nitrogen species Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- JGUZGNYPMHHYRK-UHFFFAOYSA-N rhamnetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 JGUZGNYPMHHYRK-UHFFFAOYSA-N 0.000 description 1
- 235000019246 rhodoxanthin Nutrition 0.000 description 1
- PEFASEPMJYRQBW-XMWKPCQISA-N robinin Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O4)c3)C2=O)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 PEFASEPMJYRQBW-XMWKPCQISA-N 0.000 description 1
- 229930002286 rosinidin Natural products 0.000 description 1
- GNONHFYAESLOCB-UHFFFAOYSA-O rosinidin Chemical compound [O+]=1C2=CC(OC)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(OC)=C1 GNONHFYAESLOCB-UHFFFAOYSA-O 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- DJOJDHGQRNZXQQ-AWEZNQCLSA-N sakuranetin Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)OC)=CC=C(O)C=C1 DJOJDHGQRNZXQQ-AWEZNQCLSA-N 0.000 description 1
- RNAPFFYGJWALAQ-UHFFFAOYSA-N sakuranetin Natural products O1C2=CC(C)=CC(O)=C2C(=O)CC1C1=CC=C(O)C=C1 RNAPFFYGJWALAQ-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 1
- 229930190376 scutellarin Natural products 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 235000014899 silybin Nutrition 0.000 description 1
- 229940043175 silybin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- DSAJORLEPQBKDA-AWEZNQCLSA-N sterubin Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)OC)=CC=C(O)C(O)=C1 DSAJORLEPQBKDA-AWEZNQCLSA-N 0.000 description 1
- DSAJORLEPQBKDA-UHFFFAOYSA-N sterubin Natural products O1C2=CC(OC)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 DSAJORLEPQBKDA-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000008603 tangeritin Nutrition 0.000 description 1
- UKIPVDAOZKIZJT-UHFFFAOYSA-N terflavin B Natural products C=1C(O)=C(O)C(O)=C(C=2C=3C(=O)OC=4C(O)=C(O)C=C5C(=O)OC(C=3C5=4)=C(O)C=2O)C=1C(=O)OC1C(O)C(O)C(O)OC1COC(=O)C1=CC(O)=C(O)C(O)=C1 UKIPVDAOZKIZJT-UHFFFAOYSA-N 0.000 description 1
- UKIPVDAOZKIZJT-RPMOVZCCSA-N terflavin b Chemical compound C([C@H]1OC([C@@H]([C@@H](O)[C@@H]1OC(=O)C=1C(=C(O)C(O)=C(O)C=1)C=1C=2C(=O)OC=3C(O)=C(O)C=C4C(=O)OC(C=2C4=3)=C(O)C=1O)O)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 UKIPVDAOZKIZJT-RPMOVZCCSA-N 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- FJYGFTHLNNSVPY-BBXLVSEPSA-N theaflavin digallate Chemical compound C1=C([C@@H]2[C@@H](CC3=C(O)C=C(O)C=C3O2)O)C=C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(=O)C2=C1C([C@H]1OC3=CC(O)=CC(O)=C3C[C@H]1O)=CC(O)=C2OC(=O)C1=CC(O)=C(O)C(O)=C1 FJYGFTHLNNSVPY-BBXLVSEPSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000004330 tyrosol Nutrition 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- ORXQGKIUCDPEAJ-YRNVUSSQSA-N xanthohumol Chemical compound COC1=CC(O)=C(CC=C(C)C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 ORXQGKIUCDPEAJ-YRNVUSSQSA-N 0.000 description 1
- UVBDKJHYMQEAQV-UHFFFAOYSA-N xanthohumol Natural products OC1=C(CC=C(C)C)C(OC)=CC(OC)=C1C(=O)C=CC1=CC=C(O)C=C1 UVBDKJHYMQEAQV-UHFFFAOYSA-N 0.000 description 1
- 235000008209 xanthohumol Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 150000008494 α-glucosides Chemical class 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 150000008495 β-glucosides Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Composition pour prendre soin de matières kératineuses L’invention concerne une composition pour prendre soin de matières kératineuses, comprenant, essentiellement constituée, ou constituée de : A) au moins deux antioxydants bifonctionnels choisis parmi des composés contenant de l’hydroxyle acide, servant également au moins d’agents de blanchiment, et B) au moins deux polyols qui sont liquides à température ambiante, dans laquelle au moins un des polyols est un polyol en C2-C6 ayant 2 ou 3 groupes hydroxyle, dans laquelle la composition est anhydre. Figure pour l'abrégé : néant Composition for taking care of keratinous materials The invention relates to a composition for caring for keratinous materials, comprising, essentially consisting of, or consisting of: A) at least two bifunctional antioxidants chosen from compounds containing acid hydroxyl, also serving at least as bleaching agents, and B) at least two polyols that are liquid at room temperature, wherein at least one of the polyols is a C2-C6 polyol having 2 or 3 hydroxyl groups, wherein the composition is anhydrous. Figure for the abstract: none
Description
La présente invention concerne une composition cosmétique pour prendre soin de matières kératineuses, et en particulier de la peau. La présente invention concerne en outre l’utilisation de cette composition, et en particulier sous la forme d’un produit de soin cutané.The present invention relates to a cosmetic composition for caring for keratinous materials, and in particular the skin. The present invention further relates to the use of this composition, and in particular in the form of a skin care product.
Arrière-planBackground
Le domaine cosmétique a toujours eu comme objectif ultime d’offrir des produits présentant des bénéfices pour la peau tels qu’hydratation, effet anti-âge, blanchiment, nettoyage, sensation de douceur, etc.The cosmetic field has always had the ultimate objective of offering products with benefits for the skin such as hydration, anti-aging effect, whitening, cleansing, feeling of softness, etc.
En vieillissant, la couche de peau externe (épiderme) s’amincit, bien que le nombre de couches cellulaires reste inchangé. Le nombre de cellules contenant du pigment (mélanocytes) diminue toutefois. Par conséquent, la peau apparaît pâle et translucide. De grosses taches pigmentées (taches de vieillesse, taches brunes ou lentigos) peuvent apparaître dans des zones exposées au soleil. Des changements dans le tissu conjonctif réduisent la fermeté et l’élasticité de la peau. Ceci est connu sous le nom d’élastose. Cela se remarque davantage dans les zones exposées au soleil (élastose solaire). L’élastose produit l’aspect tanné, buriné propre aux agriculteurs, marins et autres qui passent beaucoup de temps à l’extérieur. La déshydratation augmente le risque de lésion cutanée. Une mauvaise nutrition peut également avoir un impact négatif sur la peau, causant sécheresse, éruptions cutanées et poches.As we age, the outer layer of skin (epidermis) becomes thinner, although the number of cell layers remains unchanged. However, the number of cells containing pigment (melanocytes) decreases. Consequently, the skin appears pale and translucent. Large pigmented spots (age spots, brown spots, or lentigines) may appear in areas exposed to the sun. Changes in connective tissue reduce the firmness and elasticity of the skin. This is known as elastosis. This is more noticeable in areas exposed to the sun (solar elastosis). Elastosis produces the weathered, weathered appearance unique to farmers, sailors and others who spend a lot of time outdoors. Dehydration increases the risk of skin damage. Poor nutrition can also have a negative impact on the skin, causing dryness, rashes and puffiness.
D’autre part, la formation de radicaux libres est un mécanisme essentiel largement accepté conduisant au vieillissement cutané. Les radicaux libres sont des molécules hautement réactives avec des électrons non appariés qui peuvent endommager directement diverses membranes cellulaires, lipides, protéines, ARN et ADN. Les effets d’endommagement de ces espèces réactives de l’oxygène sont induits de manière interne au cours d’un métabolisme normal et de manière externe par le biais de divers stress oxydatifs. L’exposition aux UV et la pollution environnementale peuvent accélérer le vieillissement de la peau en produisant des radicaux libres dans la peau. Les antioxydants protègent les cellules de l’endommagement provoqué par le stress oxydatif en piégeant les radicaux libres et en inhibant les réactions d’oxydation consécutives. L’application topique d’antioxydants est largement utilisée dans les produits de soin cutané pour empêcher le vieillissement de la peau.On the other hand, the formation of free radicals is a widely accepted essential mechanism leading to skin aging. Free radicals are highly reactive molecules with unpaired electrons that can directly damage various cell membranes, lipids, proteins, RNA and DNA. The damaging effects of these reactive oxygen species are induced internally during normal metabolism and externally through various oxidative stresses. UV exposure and environmental pollution can accelerate skin aging by producing free radicals in the skin. Antioxidants protect cells from damage caused by oxidative stress by scavenging free radicals and inhibiting subsequent oxidation reactions. Topical application of antioxidants is widely used in skin care products to prevent skin aging.
La présente divulgation concerne des compositions et procédés d’utilisation des compositions pour apporter des bienfaits à la peau. Les compositions améliorent l’aspect de la peau et offrent de multiples avantages anti-âge et autres avantages à la peau. Les compositions sont uniques dans leur aptitude à offrir une forte efficacité antioxydante avec une sensation de douceur.The present disclosure relates to compositions and methods of using the compositions to provide benefits to the skin. The compositions improve the appearance of the skin and provide multiple anti-aging and other benefits to the skin. The compositions are unique in their ability to provide strong antioxidant efficacy with a smooth feel.
Les inventeurs ont découvert de manière surprenante une composition anhydre comprenant des composants A) au moins deux antioxydants bifonctionnels choisis parmi des composés contentant de l’hydroxyle acide, servant également au moins d’agents de blanchiment ; et B) au moins deux polyols qui sont liquides à température ambiante, dans laquelle au moins un des polyols est un polyol en C2-C6 ayant 2 ou 3 groupes hydroxyle.The inventors have surprisingly discovered an anhydrous composition comprising components A) at least two bifunctional antioxidants chosen from compounds containing the acid hydroxyl, also serving at least as bleaching agents; and B) at least two polyols which are liquid at room temperature, wherein at least one of the polyols is a C2-C6 polyol having 2 or 3 hydroxyl groups.
Selon un mode de réalisation de l’invention, le composant A), à savoir, des antioxydants bi-fonctionnels, est utilisé dans une quantité de 0,1 à 40 % en poids par rapport au poids total de la composition.According to one embodiment of the invention, component A), namely, bi-functional antioxidants, is used in an amount of 0.1 to 40% by weight relative to the total weight of the composition.
La composition selon l’invention a en particulier une texture fluide et légère, adaptée pour être utilisée en ampoule. Le composition selon l’invention est particulièrement stable avec le temps, en particulier contre le rayonnement UV.The composition according to the invention has in particular a fluid and light texture, suitable for use in an ampoule. The composition according to the invention is particularly stable over time, in particular against UV radiation.
Le sujet de l’invention est également un procédé pour prendre soin ou maquiller des matières kératineuses, en particulier la peau, par exemple, le visage, comprenant l’application topique aux matières kératineuses de la composition selon la présente invention.The subject of the invention is also a process for caring for or making up keratinous materials, in particular the skin, for example the face, comprising the topical application to the keratinous materials of the composition according to the present invention.
L’invention concerne également l’utilisation de la composition selon la présente invention pour prendre soin ou maquiller des matières kératineuses, en particulier pour prendre soin de la peau. La composition selon la présente invention présente en particulier un effet anti oxygène singulet amélioré. En conséquence, la composition selon la présente invention, en particulier dans le cas où elle est utilisée dans un produit en ampoule, est supérieure sur une peau lumineuse éclatante et/ou une peau nourrie lisse.The invention also relates to the use of the composition according to the present invention for taking care of or making up keratinous materials, in particular for taking care of the skin. The composition according to the present invention has in particular an improved anti-singlet oxygen effect. Accordingly, the composition according to the present invention, particularly when used in an ampoule product, is superior on radiant luminous skin and/or smooth nourished skin.
Modes de réalisation de l’inventionEmbodiments of the Invention
Tout au long de la description, y compris dans les revendications, le terme « comprenant un(e) » doit être entendu comme étant synonyme de « comprenant au moins un(e) », sauf mention contraire. De plus, l’expression « au moins un(e) » utilisée dans la présente description équivaut à l’expression « un(e) ou plusieurs ».Throughout the description, including in the claims, the term "comprising a" must be understood as being synonymous with "comprising at least one", unless otherwise stated. In addition, the expression "at least one" used in the present description is equivalent to the expression "one or more".
Tout au long de la description, y compris dans les revendications, un mode de réalisation défini avec « comprenant » ou similaire doit être entendu comme englobant un mode de réalisation préférable défini avec « constitué essentiellement de » et un mode de réalisation préférable défini avec « constitué de ».Throughout the description, including in the claims, an embodiment defined with "comprising" or the like should be understood to encompass a preferable embodiment defined with "consisting essentially of" and a preferable embodiment defined with " made of ".
De préférence, la « matière kératineuse » selon la présente invention est la peau. Par « peau », on entend l’ensemble de la peau du corps. De manière davantage préférée, la matière kératineuse est le visage, ou le cou, en particulier le visage.Preferably, the "keratinous material" according to the present invention is the skin. By "skin" we mean all of the skin of the body. More preferably, the keratinous material is the face, or the neck, in particular the face.
Par « application topique », on entend que la composition est appliquée ou étalée sur la surface des matières kératineuses, par exemple, au moins une zone de la peau.By “topical application”, it is meant that the composition is applied or spread over the surface of the keratinous materials, for example, at least one zone of the skin.
Dans la demande, sauf mention spécifique contraire, les teneurs, parties et pourcentages sont exprimés sur une base en poids.In the application, unless specifically stated otherwise, the contents, parts and percentages are expressed on a weight basis.
Autre que dans les exemples fonctionnels, ou sauf mention contraire, tous les nombres exprimant des quantités de composants et/ou des conditions de réaction doivent être entendu comme étant modifiés dans tous les cas par le terme « environ », avec une signification généralement connue dans l’art, par exemple, à 10 % près du nombre indiqué (par exemple « environ 10 % » signifie 9 % - 11 % et environ 2 % » signifie 1,8 % - 2,2 %).Other than in the functional examples, or unless otherwise indicated, all numbers expressing quantities of components and/or reaction conditions shall be understood to be modified in all cases by the term "about", with a meaning generally known in art, for example, to within 10% of the indicated number (eg "about 10%" means 9% - 11% and about 2%" means 1.8% - 2.2%).
Dans la demande, une plage numérique est définie avec une limite inférieure et une limite supérieure si nécessaire, de telle sorte qu’une ou plusieurs limites inférieures et une ou plusieurs limites supérieures sont données pour former une plage optionnellement en conjugaison avec une ou plusieurs plages préférées. Une plage donnée peut être définie en sélectionnant une limite inférieure et une limite supérieure qui définissent les frontières de la plage donnée. Toutes les plages définies de cette manière sont inclusives et combinables, à savoir, une quelconque limite inférieure peut être combinée avec une quelconque limite supérieure pour former une plage, pourvu que les limites inférieure et supérieure sont fournies pour modifier le même sujet. Par exemple, lorsque des plages de 60-110 et 80-120 sont indiquées pour un sujet spécifique, il doit être entendu que des plages 60-120 et 80-110 sont également envisagées et englobées. En outre, si les limites inférieures indiquées sont 1 et 2 et que les limites supérieures sont indiquées comme étant 3, 4 et 5, les plages suivantes sont toutes prévisibles et se trouvent dans la portée de la présente divulgation : 1-3, 1-4, 1 -5, 2-3, 2-4 et 2-5.In the application, a numerical range is defined with a lower limit and an upper limit if necessary, such that one or more lower limits and one or more upper limits are given to form a range optionally in conjunction with one or more ranges favourites. A given range can be defined by selecting a lower limit and an upper limit which define the borders of the given range. All ranges defined in this manner are inclusive and combinable, i.e. any lower limit may be combined with any upper limit to form a range, provided both lower and upper limits are provided to modify the same subject. For example, where ranges of 60-110 and 80-120 are stated for a specific subject, it should be understood that ranges of 60-120 and 80-110 are also contemplated and encompassed. Further, if the lower limits indicated are 1 and 2 and the upper limits are indicated as 3, 4 and 5, the following ranges are all foreseeable and fall within the scope of this disclosure: 1-3, 1- 4, 1-5, 2-3, 2-4 and 2-5.
Aux fins de la présente invention, le terme « anhydre » signifie l’absence d’eau, ou la présence d’eau dans une quantité que l’homme du métier peut déterminer comme étant exempte ou sensiblement exempte d’eau. Par exemple, une composition « anhydre » selon la présente invention peut comprendre moins de 2 %, de préférence, moins de 0,5 % en poids d’eau par rapport au poids total de la composition. Le cas échéant, de telles petites quantités d’eau peuvent être fournies par des ingrédients de la composition qui la comprennent dans une quantité résiduelle, mais ne sont pas délibérément fournies.For the purposes of the present invention, the term "anhydrous" means the absence of water, or the presence of water in an amount which one skilled in the art can determine to be free or substantially free of water. For example, an “anhydrous” composition according to the present invention can comprise less than 2%, preferably less than 0.5% by weight of water relative to the total weight of the composition. Where appropriate, such small amounts of water may be provided by ingredients in the composition which include it in a residual amount, but are not deliberately provided.
La présente invention concerne une composition pour prendre soin de matières kératineuses, comprenant, essentiellement constituée, ou constituée des composants suivants :The present invention relates to a composition for taking care of keratinous materials, comprising, essentially consisting of, or consisting of the following components:
A) au moins deux antioxydants bifonctionnels choisis parmi des composés contenant de l’hydroxyle acide, servant également au moins d’agents de blanchiment ; etA) at least two bifunctional antioxidants selected from hydroxy acid-containing compounds, also serving as at least bleaching agents; And
B) au moins deux polyols qui sont liquides à température ambiante, dans laquelle au moins un des polyols est un polyol en C2-C6 ayant 2 ou 3 groupes hydroxyle,B) at least two polyols which are liquid at room temperature, wherein at least one of the polyols is a C2-C6 polyol having 2 or 3 hydroxyl groups,
dans laquelle la composition est anhydre.wherein the composition is anhydrous.
Composant A), Antioxydants bifonctionnelsComponent A), Bifunctional antioxidants
La composition selon la présente invention comprend un composant A), au moins deux antioxydants bifonctionnels choisis parmi des composés contenant de l’hydroxyle acide, qui sert également au moins d’agent de blanchiment aux fins de la présente invention.The composition according to the present invention comprises component A), at least two bifunctional antioxidants selected from compounds containing hydroxy acid, which also serves at least as a bleaching agent for the purposes of the present invention.
Généralement, un groupe hydroxyle libre est relativement facilement oxydable. Ainsi un antioxydant contenant au moins un groupe hydroxyle est d’un grand intérêt.Generally, a free hydroxyl group is relatively easily oxidized. Thus an antioxidant containing at least one hydroxyl group is of great interest.
L’antioxydant bifonctionnel peut être de l’anthocyanine contenant un groupe hydroxyle. Les anthocyanines et leurs dérivés sont des antioxydants. Les anthrocyanines comprennent une catégorie de composés flavonoïdes responsables des couleurs rouge, violette et bleue de nombreux fruits, légumes, graines et fleurs, qui sont des composés hydrosolubles naturels. Par ailleurs, les anthocyanines sont des inhibiteurs de collagénase. L’inhibition de la collagénase aide à prévenir et réduire les rides causées par une réduction de collagène de la peau, à augmenter l’élasticité de la peau, et similaire. Les anthocyanines peuvent être obtenues d’une quelconque partie d’une variété de sources végétales, telles que les fruits, fleurs, tiges, feuilles, racines, écorces ou graines. L’homme du métier saura apprécier que certaines parties de la plante peuvent comprendre des niveaux naturels plus élevés d’anthocyanines, et ainsi ces fractions sont utilisées pour obtenir les anthocyanines souhaitées. Dans certains cas, l’antioxydant peut inclure une ou plusieurs bétaïnes. La bétatine, tout comme les anthocyanines, est disponible à partir de sources naturelles et est un antioxydant.The bifunctional antioxidant may be anthocyanin containing a hydroxyl group. Anthocyanins and their derivatives are antioxidants. Anthrocyanins include a class of flavonoid compounds responsible for the red, purple, and blue colors of many fruits, vegetables, seeds, and flowers, which are naturally occurring water-soluble compounds. Furthermore, anthocyanins are collagenase inhibitors. Collagenase inhibition helps prevent and reduce wrinkles caused by reduced skin collagen, increase skin elasticity, and the like. Anthocyanins can be obtained from any part of a variety of plant sources, such as fruits, flowers, stems, leaves, roots, barks or seeds. Those skilled in the art will appreciate that certain parts of the plant may comprise naturally higher levels of anthocyanins, and thus these fractions are used to obtain the desired anthocyanins. In some cases, the antioxidant may include one or more betaines. Betatine, like anthocyanins, is available from natural sources and is an antioxidant.
L’antioxydant bifonctionnel peut être un phénylpropanoïde contenant un groupe hydroxyle (un dérivé d’acide cinnamique). Les phénylpropanoïdes incluent : l’acide caféique, l’acide férulique, l’acide trans-férulique (y compris son pharmacophore antioxydant 2,6-dihydroxy acétophénome), l’acide 5-hydroxyférique, l’acide sinapique. Sans limiter le mode d’action de la présente invention, les phénylpropanoïdes peuvent neutraliser les radicaux libres.The bifunctional antioxidant may be a phenylpropanoid containing a hydroxyl group (a derivative of cinnamic acid). Phenylpropanoids include: caffeic acid, ferulic acid, trans-ferulic acid (including its antioxidant pharmacophore 2,6-dihydroxy acetophenome), 5-hydroxyferic acid, sinapic acid. Without limiting the mode of action of the present invention, phenylpropanoids can neutralize free radicals.
L’antioxydant bifonctionnel peut être du tanin. Les tanins utiles incluent : tanins, terflavine B, glucogalline, acide gallique et acide quercitannique.The bifunctional antioxidant may be tannin. Useful tannins include: tannins, terflavin B, glucogallin, gallic acid and quercitannic acid.
L’antioxydant bifonctionnel peut être des acides organiques contenant un groupe hydroxyle, tels que l’acide gallique, l’acide ellagique, l’acide cichorique, l’acide chlorogénique, l’acide rosmarinique, l’acide protocatéchuique ou les acides α-hydroxy, tels que l’acide lactique et l’acide glycolique et des dérivés de ceux-ci ainsi que les acides énumérés dans la catégorie du phénylpropanoïde ci-dessus.The bifunctional antioxidant can be organic acids containing a hydroxyl group, such as gallic acid, ellagic acid, cichoric acid, chlorogenic acid, rosmarinic acid, protocatechuic acid or α- hydroxy, such as lactic acid and glycolic acid and derivatives thereof as well as the acids listed in the phenylpropanoid category above.
L’antioxydant bifonctionnel peut être de la vitamine C ou des dérivés de celle-ci contenant un groupe hydroxyle, incluant l’acide ascorbique, l’ascorbate de sodium, le glycoside d’ascorbyle, l’ascorbate de glucosamine, l’acétate d’ascorbyle et similaire. Par ailleurs, il est possible d’utiliser des plantes dérivées d’une grande quantité de vitamine C, comme des extraits de myrciaria dubia, acérola, emblica officinalis, et des bioflavonoïdes d’églantiers et agrumes, incluant les biflavonoïdes hydrosolubles, par exemple, hespéridin méthyl chalcone.The bifunctional antioxidant can be vitamin C or derivatives thereof containing a hydroxyl group, including ascorbic acid, sodium ascorbate, ascorbyl glycoside, glucosamine ascorbate, acetate of ascorbyl and the like. Furthermore, it is possible to use plants derived from a large amount of vitamin C, such as extracts of myrciaria dubia, acerola, emblica officinalis, and bioflavonoids from rose hips and citrus fruits, including water-soluble biflavonoids, for example, hesperidin methyl chalcone.
D’autres exemples d’antioxydant bifonctionnel peuvent comprendre l’hydroxytyrosolrutine, le sésame phénol, les acides gras polyinsaturés et les antioxydants à base de soufre contenant un groupe hydroxyle.Other examples of bifunctional antioxidant may include hydroxytyrosolrutin, sesame phenol, polyunsaturated fatty acids, and sulfur-based antioxidants containing a hydroxyl group.
Sans être limité par une quelconque théorie connue, on pense que l’utilisation en parallèle d’au moins deux antioxydants bifonctionnels ci-dessus peut être particulièrement bénéfique. Selon un mode de réalisation, l’un des au moins deux antioxydants bifonctionnels utilisés en parallèle peut être une vitamine ou un dérivé de celle-ci, telle que la vitamine C ou des dérivés de celle-ci. Par exemple, la vitamine C ou la vitamine E peut être préférablement utilisée, par exemple la vitamine C. Selon un mode de réalisation, la vitamine ou un dérivé de celle-ci, le cas échéant, peut être présente dans une quantité de 1 à 30 % en poids, de préférence, de 5 à 25 % en poids ou de 7 à 18 % en poids, par rapport au poids total de la composition.Without being bound by any known theory, it is believed that the concurrent use of at least two of the above bifunctional antioxidants may be particularly beneficial. According to one embodiment, one of the at least two bifunctional antioxidants used in parallel can be a vitamin or a derivative thereof, such as vitamin C or derivatives thereof. For example, vitamin C or vitamin E can preferably be used, for example vitamin C. According to one embodiment, the vitamin or a derivative thereof, if any, can be present in an amount of 1 to 30% by weight, preferably from 5 to 25% by weight or from 7 to 18% by weight, relative to the total weight of the composition.
Selon un autre mode de réalisation pour les au moins deux antioxydants bifonctionnels utilisés en parallèle, l’un des au moins deux antioxydants bifonctionnels peut être un acide organique contenant de l’hydroxyle tel que : acide caféique, acide férulique, acide trans-férulique, acide sinapique, acide gallique, acide ellagique, acide cichorique, acide chlorogénique, acide rosmarinique, acide protocatéchuique, acide lactique et/ou acide glycolique. Par exemple, il est préférable d’utiliser un acide férulique, un acide trans-férulique et/ou un acide ellagique, par exemple, un acide férulique. Selon un mode de réalisation, l’acide organique contenant de l’hydroxyle, le cas échéant, peut être présent dans une quantité de 0,01 à 20 % en poids, de préférence, de 0,1 à 15 % en poids ou de 0,5 à 3 % en poids, par rapport au poids total de la composition.According to another embodiment for the at least two bifunctional antioxidants used in parallel, one of the at least two bifunctional antioxidants can be an organic acid containing hydroxyl such as: caffeic acid, ferulic acid, trans-ferulic acid, sinapic acid, gallic acid, ellagic acid, cichoric acid, chlorogenic acid, rosmarinic acid, protocatechuic acid, lactic acid and/or glycolic acid. For example, it is preferable to use a ferulic acid, a trans-ferulic acid and/or an ellagic acid, for example, a ferulic acid. According to one embodiment, the hydroxyl-containing organic acid, if present, may be present in an amount of 0.01 to 20% by weight, preferably, 0.1 to 15% by weight or 0.5 to 3% by weight, relative to the total weight of the composition.
Le composant A) peut être présent dans une quantité de 0,01 à 40 % en poids, de préférence, de 0,1 à 35 % en poids, 1 à 30 % en poids ou 5 à 20 % en poids, par rapport au poids total de la composition.Component A) may be present in an amount of 0.01 to 40% by weight, preferably 0.1 to 35% by weight, 1 to 30% by weight or 5 to 20% by weight, relative to the total weight of the composition.
Composant B), PolyolComponent B), Polyol
La composition selon la présente invention comprend un polyol, qui est liquide à température ambiante (25 ℃), choisi de préférence en particulier parmi des polyols ayant en particulier de 2 à 20 atomes de carbone, ayant de préférence de 2 à 10 atomes de carbone et ayant préférentiellement de 2 à 6 atomes de carbone, tels que glycérine, propylène glycol, butylène glycol, pentylène glycol, hexylène glycol, dipropylène glycol et diéthylène glycol.The composition according to the present invention comprises a polyol, which is liquid at room temperature (25 ℃), preferably chosen in particular from polyols having in particular from 2 to 20 carbon atoms, preferably having from 2 to 10 carbon atoms and preferably having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol and diethylene glycol.
De préférence, la composition selon la présente invention peut comprendre en parallèle au moins deux polyols. Selon un mode de réalisation de l’invention, sur les au moins deux polyols utilisés en parallèle, au moins un des polyols est un polyol en C2-C6 ayant 2 ou 3 groupes hydroxyle.Preferably, the composition according to the present invention may comprise at least two polyols in parallel. According to one embodiment of the invention, of the at least two polyols used in parallel, at least one of the polyols is a C2-C6 polyol having 2 or 3 hydroxyl groups.
Selon un mode de réalisation de l’invention, sur les au moins deux polyols utilisés en parallèle, au moins deux, de préférence l’ensemble des polyols sont des alcools faibles, ayant de préférence chacun de 2 à 6 atomes de carbone.According to one embodiment of the invention, of the at least two polyols used in parallel, at least two, preferably all of the polyols are weak alcohols, each preferably having from 2 to 6 carbon atoms.
Selon un mode de réalisation de l’invention, sur les au moins deux polyols utilisés en parallèle, au moins deux polyols comprennent chacun 2 ou 3 groupes hydroxyle, ayant de préférence chacun de 2 à 6 atomes de carbone.According to one embodiment of the invention, of the at least two polyols used in parallel, at least two polyols each comprise 2 or 3 hydroxyl groups, each preferably having from 2 to 6 carbon atoms.
Selon un autre exemple de mode de réalisation de l’invention, sur les au moins deux polyols utilisés en parallèle, au moins deux, de préférence l’ensemble des polyols sont chacun des dérivés d’un même alcane. Par exemple, une combinaison d’éthylène glycol et de diéthylène glycol, qui sont considérés comme des dérivés d’éthane, peut être utilisée. En tant qu’autre exemple, une combinaison de deux, trois ou quatre de propylène glycol, dipropylène glycol, glycérine et diglycérine qui sont considérés comme des dérivés de propane, peut être utilisée.According to another exemplary embodiment of the invention, of the at least two polyols used in parallel, at least two, preferably all of the polyols are each derivatives of the same alkane. For example, a combination of ethylene glycol and diethylene glycol, which are considered derivatives of ethane, can be used. As another example, a combination of two, three or four of propylene glycol, dipropylene glycol, glycerin and diglycerin which are considered derivatives of propane, can be used.
Comme susmentionné, le composant A) implique au moins deux antioxydants bifonctionnels choisis parmi un composé contenant de l’hydroxyle acide, qui comprennent un groupe hydroxyle, ainsi qu’éventuellement un groupe carboxyle. En conséquence, pour une dissolution et/ou stabilité favorables, les au moins deux polyols utilisés en parallèle sont spécifiquement sélectionnés comme correspondant au composant A), correspondant spécifiquement à l’agencement hydroxyle de celui-ci. Par exemple, un polyol des au moins deux polyols utilisés en parallèle peut avoir deux groupes hydroxyle adjacents, tels qu’éthylène glycol, 1,2-propylène glycol ou glycérine ; alors que l’autre polyol des au moins deux polyols utilisés en parallèle peut avoir des groupes hydroxyle non adjacents, par exemple, 1,3-propylène glycol, ou encore des groupes hydroxyles aussi distants que possible, par exemple, dipropylène glycol.As mentioned above, component A) involves at least two bifunctional antioxidants selected from an acidic hydroxyl-containing compound, which include a hydroxyl group, as well as optionally a carboxyl group. Accordingly, for favorable dissolution and/or stability, the at least two polyols used in parallel are specifically selected as corresponding to component A), specifically corresponding to the hydroxyl arrangement thereof. For example, a polyol of the at least two polyols used in parallel can have two adjacent hydroxyl groups, such as ethylene glycol, 1,2-propylene glycol or glycerin; while the other polyol of the at least two polyols used in parallel can have non-adjacent hydroxyl groups, for example, 1,3-propylene glycol, or even hydroxyl groups as far apart as possible, for example, dipropylene glycol.
Des exemples d’au moins deux polyols utilisés en parallèle peuvent être constitués d’une combinaison de dipropylène glycol et de glycérine ; d’une combinaison de propylène glycol, dipropylène glycol et glycérine ; et d’une combinaison de propylène glycol, dipropylène glycol, glycérine et diglycérine.Examples of two or more polyols used in parallel can consist of a combination of dipropylene glycol and glycerine; a combination of propylene glycol, dipropylene glycol and glycerin; and a combination of propylene glycol, dipropylene glycol, glycerin and diglycerin.
Selon un mode de réalisation de l’invention, sur les au moins deux polyols utilisés en parallèle dans le composant B), les au moins deux polyols peuvent être utilisés dans des quantités similaires. Par exemple, pour le composant B), les au moins deux polyols utilisés en parallèle peuvent chacun représenter 20-55 % en poids, de préférence, 30-50 % en poids ou 40-50 % en poids, par rapport au poids total du composant B).According to one embodiment of the invention, of the at least two polyols used in parallel in component B), the at least two polyols can be used in similar amounts. For example, for component B), the at least two polyols used in parallel can each represent 20-55% by weight, preferably 30-50% by weight or 40-50% by weight, relative to the total weight of the component B).
Le composant B) peut être présent dans une quantité de 60-99,99 % en poids, de préférence, 65-99,9 % en poids, 70-99 % en poids, ou 80-95 % en poids, par rapport au poids total de la composition.Component B) may be present in an amount of 60-99.99% by weight, preferably 65-99.9% by weight, 70-99% by weight, or 80-95% by weight, with respect to the total weight of the composition.
Forme anhydreAnhydrous form
Aux fins de la présente invention, la composition selon la présente invention est essentiellement sous une forme anhydre. Selon la présente invention, on évite d’inclure de l’eau ou de l’humidité dans la composition ; toutefois, l’homme du métier comprendra aisément que l’eau ne peut pas être supprimée à 100 %. Par exemple, bien que de l’eau ne soit pas intentionnellement ajoutée, elle peut être fournie par des ingrédients de la composition qui la contiennent dans une quantité résiduelle, peut être incorporée pendant la production ou peut être absorbée de l’atmosphère ambiante pendant la production et/ou le stockage.For the purposes of the present invention, the composition according to the present invention is essentially in an anhydrous form. According to the present invention, the inclusion of water or humidity in the composition is avoided; however, those skilled in the art will readily appreciate that water cannot be 100% removed. For example, although water is not intentionally added, it may be supplied by composition ingredients which contain it in a residual amount, may be incorporated during production, or may be absorbed from the ambient atmosphere during processing. production and/or storage.
En conséquence, aux fins de la présente invention, le terme « anhydre » signifie l’absence d’eau, ou la présence d’eau dans une quantité que l’homme du métier peut déterminer comme étant exempte ou sensiblement exempte d’eau. Par exemple, une composition « anhydre » selon la présente invention peut comprendre moins de 2 %, de préférence, moins de 0,5 % en poids d’eau par rapport au poids total de la composition. De préférence, une composition « anhydre » selon la présente invention ne comprend pas une quantité détectable d’eau, dans laquelle la « quantité détectable » signifie une quantité qui peut être détectée par un dispositif d’ordinaire utilisé dans l’art pour mesurer la teneur en eau.Accordingly, for the purposes of the present invention, the term "anhydrous" means the absence of water, or the presence of water in an amount which one skilled in the art can determine to be free or substantially free of water. For example, an “anhydrous” composition according to the present invention can comprise less than 2%, preferably less than 0.5% by weight of water relative to the total weight of the composition. Preferably, an "anhydrous" composition according to the present invention does not comprise a detectable amount of water, wherein the "detectable amount" means an amount which can be detected by a device ordinarily used in the art for measuring the water content.
Eventuellement, les composants A) et B), ainsi que, le cas échéant, n’importe quels autres composants, sont soumis à une étape d’élimination d’eau avant d’être incorporés dans la composition de la présente invention. Les moyens techniques d’élimination d’eau ne sont pas particulièrement limités, pourvu que la composition obtenue soit « anhydre ».Optionally, components A) and B), as well as, where appropriate, any other components, are subjected to a water removal step before being incorporated into the composition of the present invention. The technical means of removing water are not particularly limited, provided that the composition obtained is "anhydrous".
Antioxydants supplémentairesAdditional Antioxidants
En plus de l’antioxydant bifonctionnel utilisé pour le composant A), la composition selon la présente invention peut éventuellement comprendre un antioxydant supplémentaire autre que ceux spécifiés pour le composant A) selon la présente invention.In addition to the bifunctional antioxidant used for component A), the composition according to the present invention may optionally comprise an additional antioxidant other than those specified for component A) according to the present invention.
Les antioxydants supplémentaires utilisés peuvent inclure des antioxydants phytochimiques exogènes naturels tels que des phénols et caroténoïdes.Additional antioxidants used may include natural exogenous antioxidant phytochemicals such as phenols and carotenoids.
L’antioxydant supplémentaire peut inclure des flavonoïdes. Les flavonoïdes constituent une vaste catégorie de plus de 5 000 phytochimiques polyphénoliques avec des propriétés antioxydantes qui agissent par piégeage des radicaux libres directs. Les fllavonoïdes ont des effets anti-inflammatoires, antibactériens, antiviraux, anti-allergiques, anti-mutagènes, anti-thrombotiques, anti-tumoraux et vasodilatateurs et ces méthodes d’action peuvent également être utilisés pour prévenir, soulager ou éliminer l’endommagement oxydatif d’instruments dentaires. Les flavonoïdes peuvent présenter des propriétés de chélation avec des ions métalliques et peuvent atténuer l’endommagement oxydatif des ions métalliques par des ions chélateurs. La formation et la stabilité du flavonoïde-chélate métallique dépend de la fonction de la structure. Des flavonoïdes ayant une fraction de catéchol et ayant une liaison hydrogène entre les groupes hydroxyle à la position 5 et à la position 3 ont des propriétés de chélation.Additional antioxidant may include flavonoids. Flavonoids are a broad class of over 5,000 polyphenol phytochemicals with antioxidant properties that work by scavenging direct free radicals. Flavonoids have anti-inflammatory, antibacterial, antiviral, anti-allergic, anti-mutagenic, anti-thrombotic, anti-tumor and vasodilator effects and these methods of action can also be used to prevent, relieve or eliminate oxidative damage of dental instruments. Flavonoids can exhibit chelating properties with metal ions and can attenuate oxidative damage to metal ions by chelating ions. The formation and stability of the flavonoid-metal chelate depends on the function of the structure. Flavonoids having a catechol moiety and having a hydrogen bond between the 5-position and 3-position hydroxyl groups have chelating properties.
Du sésamum indicum ou de la lignane peuvent également être ajoutés. Le sésame et ses lignanes (composés fibreux associés au sésame) agissent comme des antioxydants. La lignane de graines de sésame améliore de manière significative l’activité de la vitamine E.Sesamum indicum or lignan can also be added. Sesame and its lignans (fibrous compounds associated with sesame) act as antioxidants. Sesame seed lignan significantly enhances vitamin E activity.
Le flavonoïde peut être une flavanone (un dérivé de 2,3-dihydro-2-phénylbenzopyran-4-one). Les flavanones incluent : scutellarine, ériodictine, hespérétine, hespéridine, sylvestre, isosakuranétine, naringénine, naringine, pinocine, tangrine (poncirine)), sakuranétine, glycosides de sakura et 7-O-méthyl ergophénol (Sterubin).The flavonoid may be a flavanone (a derivative of 2,3-dihydro-2-phenylbenzopyran-4-one). Flavanones include: scutellarin, eriodictin, hesperetin, hesperidin, sylvester, isosakuranetin, naringenin, naringin, pinocin, tangrine (poncirin), sakuranetin, sakura glycosides and 7-O-methyl ergophenol (Sterubin).
Le flavonoïde peut être un dihydroflavonol (un dérivé de 3-hydroxy-2,3-dihydro-2-phénylbenzopyran-4-one). Les flavanols incluent : taxifoline, aromadédrine, chrysandroside A, chrysandroside B, xéractinol, astilbine et flavonol.The flavonoid may be a dihydroflavonol (a derivative of 3-hydroxy-2,3-dihydro-2-phenylbenzopyran-4-one). Flavanols include: taxifolin, aromadrin, chrysandroside A, chrysandroside B, xeractinol, astilbine and flavonol.
Le flavonoïde peut être un flavonoïde (un dérivé de 2-phénylbenzopyran-4-one). Les flavonoïdes incluent : Apigénine, lutéoline, tangéritine, chrysine, baicaléine, baicaléine sauvage, wogonine, flavonoïdes synthétiques : diosmine et esters de flavonoïdes.The flavonoid may be a flavonoid (a derivative of 2-phenylbenzopyran-4-one). Flavonoids include: Apigenin, Luteolin, Tangeritin, Chrysin, Baicalein, Wild Baicalein, Wogonin, Synthetic Flavonoids: Diosmin and Flavonoid Esters.
Le flavonoïde peut être un flavonol (un dérivé de 3-hydroxy-2-phénylbenzopyran-4-one). Les flavonols incluent : 3-hydroxyflavone, rhodoxanthin, quercétine, galangine, dermatan de coton, kaempférol, kaempférol, isorhamnétine, pigment de mûre, myricétine, naringine (Natsudaidain), flavonol musqué (Pachypodol), quercétine, rhammosine de méthyle, rhamnétine, azaléine, hypéroside, isoquercétine, kaempférol, myricétine, glycosides daim, robinine, rutine, spirée, xanthorhamnine, amurensine, icariine et tracuridine.The flavonoid may be a flavonol (a derivative of 3-hydroxy-2-phenylbenzopyran-4-one). Flavonols include: 3-hydroxyflavone, rhodoxanthin, quercetin, galangin, cotton dermatan, kaempferol, kaempferol, isorhamnetin, mulberry pigment, myricetin, naringin (Natsudaidain), musk flavonol (Pachypodol), quercetin, methyl rhammosin, rhamnetin, azalein , hyperoside, isoquercetin, kaempferol, myricetin, suede glycosides, robinin, rutin, spirea, xanthorhamnine, amurensin, icariin and tracuridine.
Le flavonoïde peut être un flavan-3-ol (un dérivé de 2-phényl-3,4-dihydro-2H-benzopyran-3-ol). Le flavan-3-ol inclut : catéchine, épicatéchine, épigallocatéchine, gallate d’épicatéchine, gallate d’épigallocatéchine, épiafzéléchine, fisetinidol, guibourtinidol, mesquitol et robinétinidol.The flavonoid may be flavan-3-ol (a derivative of 2-phenyl-3,4-dihydro-2H-benzopyran-3-ol). Flavan-3-ol includes: catechin, epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate, epiafzelechin, fisetinidol, guibourtinidol, mesquitol and robinetinidol.
Le flavonoïde peut être un flavan-4-ol (un dérivé de 2-phénylchroman-4-ol). Les flavan-4-ols incluent : apiforol et lutéoforol.The flavonoid may be a flavan-4-ol (a derivative of 2-phenylchroman-4-ol). Flavan-4-ols include: apiforol and luteoforol.
Le flavonoïde peut être une isoflavone (un dérivé de 3-phénylbenzopyran-4-one). Les isoflavones incluent : génistéine, daidzéine, garbanine A, formononétine, et équol métabolites de la daidzéine.The flavonoid may be an isoflavone (a derivative of 3-phenylbenzopyran-4-one). Isoflavones include: genistein, daidzein, garbanin A, formononetin, and equol metabolites of daidzein.
L’antioxydant supplémentaire peut être une anthocyanine (un dérivé de cation de 2-phénylbenzopyranoside). Les anthocyanine incluent : aurantinidine, cyanidine, delphinidine, europinidine, lutéolinidine, pélargonidine, malvidine, péonyidine (Péonidine)), pigment de gloire du matin (Pétunidine), pigment rose (Rosinidine) et xanthone.The additional antioxidant may be an anthocyanin (a cation derivative of 2-phenylbenzopyranoside). Anthocyanins include: aurantinidin, cyanidin, delphinidin, europinidin, luteolinidin, pelargonidin, malvidin, peonyidin (Peonidin)), morning glory pigment (Petunidin), pink pigment (Rosinidin) and xanthone.
L’antioxydant supplémentaire peut être de la dihydrochalcone (un dérivé de 1,3-diphényl-1-propanone). Le dihydrochalcone inclut : phlorétine, dihydrochalcone phloridin cisplatine, aspalathine, naringin dihydrochalcone, néohespéridin dihydrochalcone et nothofagine. Le mode d’action de la présente invention n’est pas limité, mais la dihydrochalcone peut exercer un effet antioxydant en réduisant les radicaux libres tels que l’oxygène actif et les espèces réactives de l’azote.The additional antioxidant may be dihydrochalcone (a derivative of 1,3-diphenyl-1-propanone). Dihydrochalcone includes: phloretin, dihydrochalcone phloridin cisplatin, aspalathin, naringin dihydrochalcone, neohesperidin dihydrochalcone and nothofagin. The mode of action of the present invention is not limited, but dihydrochalcone can exert antioxidant effect by reducing free radicals such as active oxygen and reactive nitrogen species.
L’antioxydant supplémentaire peut être de la chalcone (un dérivé de 1,3-diphényl-2-propén-1-one). La chalcone inclut : zirconium, okanine, carthame, maréine, sophoradine, xanthohumol, flavokvaïne A, flavokavaïne B, flavokavaïne C et saflacone synthétique.The additional antioxidant may be chalcone (a derivative of 1,3-diphenyl-2-propen-1-one). Chalcone includes: zirconium, okanine, safflower, marein, sophoradine, xanthohumol, flavokvain A, flavokavain B, flavokavain C and synthetic saflacone.
L’antioxydant supplémentaire peut être un curcuminoïde. Les curcuminoïdes incluent : curcumin, déméthoxycurcumin, bis-déméthoxycurcumin, tétrahydrocurcumin et tétrahydrocurcumin. Le curcumin et le tétrahydrocurcumin peuvent être dérivés du rhizome de turmérique. Le tétrahydrocurcumin, un métabolite du curcumin, s’est avéré être un antioxydant plus puissant et plus stable que le curcumin.The additional antioxidant may be a curcuminoid. Curcuminoids include: curcumin, demethoxycurcumin, bis-demethoxycurcumin, tetrahydrocurcumin, and tetrahydrocurcumin. Curcumin and tetrahydrocurcumin can be derived from the rhizome of turmeric. Tetrahydrocurcumin, a metabolite of curcumin, has been shown to be a stronger and more stable antioxidant than curcumin.
L’antioxydant supplémentaire peut être un stilbénoïde. Les stilbénoïdes incluent : resvératrol, red sandalwood et paclitaxel. Le resvératrol peut inclure, mais sans s’y limiter : 3,5,4'-trihydroxyindole, 3,4,3',5'-tétrahydroxyindole (cétotriol), 2,3',4,5'- tétrahydroxyindole (oxyde de resvératrol), 4,4'-dihydroxyindole et ses dérivés alpha et bêta glucoside, galactoside et mannoside.The additional antioxidant may be a stilbenoid. Stilbenoids include: resveratrol, red sandalwood and paclitaxel. Resveratrol may include, but is not limited to: 3,5,4'-trihydroxyindole, 3,4,3',5'-tetrahydroxyindole (ketotriol), 2,3',4,5'-tetrahydroxyindole (ketotriol), resveratrol), 4,4'-dihydroxyindole and its derivatives alpha and beta glucoside, galactoside and mannoside.
L’antioxydant supplémentaire peut être de la coumarine (un dérivé de 2H-benzopyran-2-one). Les coumarines incluent : 4-hydroxycoumarine, umbelliférone, aesculétine, herniarine, auraptène et dicoumarine.The additional antioxidant may be coumarin (a derivative of 2H-benzopyran-2-one). Coumarins include: 4-hydroxycoumarin, umbelliferone, aesculetin, herniarin, aurapten and dicoumarin.
L’antioxydant supplémentaire peut être un caroténoïde. Les caroténoïes incluent : bêta-carotène, alpha-carotène, gamma-carotène, bêta-cryptoxanthine, lycopène, lutéine et idébénone.The additional antioxidant may be a carotenoid. Carotenoids include: beta-carotene, alpha-carotene, gamma-carotene, beta-cryptoxanthin, lycopene, lutein and idebenone.
L’antioxydant supplémentaire peut être : xanthone, hydroxytoluène butylé, 2,6-di-tert-butylphénol, 2,4-diméthyl-6-tert-butylphénol, eugénol, acétylcystéine, S-allylcystéine, pyridone (Barbigérone), acide chébulagique, édaravone, éthoxyquine, idébénone, mélatonine, sérotonine n-acétylique, acide nordihydroguaiarétique, oléotanthale, oléuropéine, paradol, paclitaxel, probucol, propyl gallate, pyrithione, diglucoside de lignane de lin, sésamine, silybine, silymarine, théaflavines, digallate de théaflavines, thymoquinone, trolox, tyrosol.Additional antioxidant may be: xanthone, butylated hydroxytoluene, 2,6-di-tert-butylphenol, 2,4-dimethyl-6-tert-butylphenol, eugenol, acetylcysteine, S-allylcysteine, pyridone (Barbigerone), chebulagic acid, edaravone, ethoxyquin, idebenone, melatonin, n-acetyl serotonin, nordihydroguaiaretic acid, oleotanthale, oleeuropein, paradol, paclitaxel, probucol, propyl gallate, pyrithione, flax lignan diglucoside, sesamin, silybin, silymarin, theaflavins, theaflavin digallate, thymoquinone , trolox, tyrosol.
Le sésamum indicum ou la lignane de sésame peut également être utilisé(e). Le sésame ou ses lignanes (composés fibreux associés au sésame) agissent comme des antioxydants. La lignane des graines de sésame améliore de manière significative l’activité de la vitamine E.Sesamum indicum or sesame lignan can also be used. Sesame or its lignans (fibrous compounds associated with sesame) act as antioxidants. Sesame seed lignan significantly enhances vitamin E activity.
Par ailleurs, des caroténoïdes, en particulier du type lutéines, sont également des antioxydants utiles qui peuvent être utilisés. Les caroténoïdes de type lutéines incluent des molécules telles que lutéine, canthaxantine, cryptoxanthine, zéaxanthine et astaxanthine. Les composés de luténie protègent les composés tels que la vitamine A, la vitamine E et autres caroténoïdes.Furthermore, carotenoids, particularly of the lutein type, are also useful antioxidants which can be used. Lutein-like carotenoids include molecules such as lutein, canthaxanthin, cryptoxanthin, zeaxanthin, and astaxanthin. Lutenia compounds protect compounds such as vitamin A, vitamin E and other carotenoids.
L’antioxydant supplémentaire décrit ci-dessus peut également se présenter selon l’invention dans une quantité de 0,001 à 10 % en poids, de préférence, de 0,1 à 7 % en poids, ou de préférence, de 0,5 à 5 % en poids, par rapport au poids total de la composition de la présente invention.The additional antioxidant described above can also be present according to the invention in an amount of 0.001 to 10% by weight, preferably 0.1 to 7% by weight, or preferably 0.5 to 5 % by weight, relative to the total weight of the composition of the present invention.
ConservateurConservative
Pour l’utilisation de la présente invention, la composition selon la présente invention peut éventuellement comprendre un conservateur. Le conservateur utile selon la présente invention peut être un quelconque conservateur utilisé traditionnellement pour les cosmétiques, en particulier pour des produits en ampoule.For the use of the present invention, the composition according to the present invention may optionally comprise a preservative. The preservative useful according to the present invention can be any preservative traditionally used for cosmetics, in particular for products in ampoules.
Par exemple, les conservateurs qui peuvent être utilisés selon la présente invention comprennent la méthylchloroisothiazolinone, l’urée d’imidazolidinyle, les dérivés d’hydantoïne, tels que le DMDMH, l’ester de parahydroxybenzoate, le phénoxyéthanol, l’alcool benzylique, la chlorphénésine, l’acide benzoïque et un sel de ceux-ci, tel que le benzoate de sodium, le sorbate de potassium, l’hydroxyacétophénone, un conservateur à base d’acides aminés, l’octanate de sorbitan, le caprylate de glycérol et similaire.For example, preservatives which can be used according to the present invention include methylchloroisothiazolinone, imidazolidinyl urea, hydantoin derivatives, such as DMDMH, parahydroxybenzoate ester, phenoxyethanol, benzyl alcohol, chlorphenesin, benzoic acid and a salt thereof, such as sodium benzoate, potassium sorbate, hydroxyacetophenone, amino acid preservative, sorbitan octanate, glycerol caprylate and similar.
Le conservateur peut être présent selon l’invention dans une quantité de 0,01 à 5 %, de préférence, de 0,01 % à 3 %, de préférence, de 0,01 % à 1 %, par rapport au poids total de la composition de la présente invention.The preservative may be present according to the invention in an amount of 0.01 to 5%, preferably 0.01% to 3%, preferably 0.01% to 1%, relative to the total weight of the composition of the present invention.
Agent gélifiantGelling agent
En tant qu’agents gélifiants, on peut mentionner les polymères de carboxyvinyle tels que Carbopols® (Carbomères) et le pémulène tel que Pemulen TR1® et Pemulen TR2® (copolymère d’acrylate/alkylacrylate en C10-C30) ; les polyacrylamides, par exemple copolymères réticulés commercialisés sous les noms Sepigel 305® (nom CTFA : polyacrylamide/C13-14 isoparaffine/Laureth 7) ou Simulgel 600 (nom CTFA : acrylamide/copolymère de sodium acryloyldiméthyltaurate/isohexadécane/polysorbate 80) par la société Seppic ; les polymères et copolymères d’acide 2-acrylamido-2-méthylpropanesulphonique, éventuellement réticulés et/ou neutralisés, tels que le polyacide 2-acrylamido-2-méthylpropanesulphonique commercialisé par Hoechst sous la marque « Hostacerin AMPS® » (nom CTFA : ammonium polyacryloyldiméthyl taurate ou SIMULGEL 800® commercialisé par la société SEPPIC (nom CTFA : sodium polyacryolyldiméthyl taurate / polysorbate 80 / sorbitan oléate) ; les copolymères d’acide 2-acrylamido-2-méthylpropanesulphonique et d’acrylate d’hydroxyéthyle tels que SIMULGEL NS® et SEPINOV EMT 10® commercialisés par la société SEPPIC, les dérivés de cellulose tels qu’hydroxyéthylcellulose, polysaccharides et en particulier, les gommes telles que gomme de xanthane, gomme de guar ou caroube, des dérivés hydrosolubles ou hydrodispersables tels que silicones acryliques, silicones de polyéther et silicones cationiques et leurs mélanges.As gelling agents, mention may be made of carboxyvinyl polymers such as Carbopols® (Carbomers) and pemulene such as Pemulen TR1® and Pemulen TR2® (acrylate/alkylacrylate C10-C30 copolymer); polyacrylamides, for example cross-linked copolymers sold under the names Sepigel 305® (CTFA name: polyacrylamide/C13-14 isoparaffin/Laureth 7) or Simulgel 600 (CTFA name: acrylamide/sodium acryloyldimethyltaurate/isohexadecane/polysorbate 80 copolymer) by the company Seppic; polymers and copolymers of 2-acrylamido-2-methylpropanesulphonic acid, optionally crosslinked and/or neutralized, such as the polyacid 2-acrylamido-2-methylpropanesulphonic marketed by Hoechst under the trademark "Hostacerin AMPS®" (CTFA name: ammonium polyacryloyldimethyl taurate or SIMULGEL 800® marketed by the company SEPPIC (CTFA name: sodium polyacryolyldimethyl taurate/polysorbate 80/sorbitan oleate); copolymers of 2-acrylamido-2-methylpropanesulphonic acid and hydroxyethyl acrylate such as SIMULGEL NS® and SEPINOV EMT 10® marketed by the company SEPPIC, cellulose derivatives such as hydroxyethylcellulose, polysaccharides and in particular gums such as xanthan gum, guar gum or carob, water-soluble or water-dispersible derivatives such as acrylic silicones, silicones of polyether and cationic silicones and mixtures thereof.
Dans un mode de réalisation particulièrement préféré, la composition selon l’invention comprend au moins un polymère et un copolymère d’acide 2-acrylamido-2-méthylpropanesulfonique éventuellement réticulé et/ou neutralisé, tel que l’acide polyacrylique, l’acide 2-acrylamido-2-méthylpropanesulfonique et au moins un polymère de carbovinyle tel que des carbomères. De préférence, la composition selon l’invention comprend le polyacide 2-acrylamido-2-méthylpropanesulphonique commercialisé par la société Hoechst sous la marque « Hostacerin AMPS® » (nom CTFA : ammonium polyacryloyldiméthyltaurate) et au moins un polymère de carboxyvinyle tel que les Carbopols® (Carbomères).In a particularly preferred embodiment, the composition according to the invention comprises at least one polymer and one copolymer of optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid, such as polyacrylic acid, 2 -acrylamido-2-methylpropanesulfonic and at least one carbovinyl polymer such as carbomers. Preferably, the composition according to the invention comprises the polyacid 2-acrylamido-2-methylpropanesulphonic marketed by the company Hoechst under the trademark "Hostacerin AMPS®" (CTFA name: ammonium polyacryloyldimethyltaurate) and at least one carboxyvinyl polymer such as Carbopols ® (Carbomers).
Les agents gélifiants peuvent être présents dans la composition selon l’invention, en particulier dans une quantité de 0,1 % à 3 % en poids, ou en particulier, de 0,5 % à 2 % en poids par rapport au poids total de la composition.The gelling agents may be present in the composition according to the invention, in particular in an amount of 0.1% to 3% by weight, or in particular, from 0.5% to 2% by weight relative to the total weight of the composition.
Adjuvantadjuvant
D’une manière connue, les formes de dose destinées à une application topique peuvent également comprendre des adjuvants qui sont habituels dans le domaine cosmétique, pharmaceutique et/ou dermatologique, tels que des agents gélifiants, des agents actifs hydrophiles ou lipophiles, des parfums, charges, filtres, régulateurs de pH, absorbeurs d’odeurs et colorants. Les quantités de ces divers adjuvants sont celles d’ordinaire utilisées dans le domaine en considération, et par exemple, de 0,01 à 20 % du poids total de la composition. Ces adjuvants, en fonction de leur nature, peuvent être introduits dans la phase aqueuse.In a known way, the dose forms intended for topical application can also comprise adjuvants which are usual in the cosmetic, pharmaceutical and/or dermatological field, such as gelling agents, hydrophilic or lipophilic active agents, perfumes, fillers, filters, pH regulators, odor absorbers and colorants. The amounts of these various adjuvants are those ordinarily used in the field under consideration, and for example, from 0.01 to 20% of the total weight of the composition. These adjuvants, depending on their nature, can be introduced into the aqueous phase.
Ces adjuvants et leurs concentrations peuvent être tels qu’ils ne modifient pas la propriété souhaitée de la composition de l’invention.These adjuvants and their concentrations may be such that they do not modify the desired property of the composition of the invention.
Ingrédient actif supplémentaireAdditional active ingredient
La composition selon l’invention peut comprendre avantageusement un ou plusieurs ingrédients actifs supplémentaires, en particulier, cosmétiques, dermatologiques ou pharmaceutiques.The composition according to the invention can advantageously comprise one or more additional active ingredients, in particular cosmetic, dermatological or pharmaceutical.
Dans le contexte de la présente invention, un ingrédient actif supplémentaire est un ingrédient actif autre que le composant A) présent dans la composition et que les autres agents actifs définis de manière particulière ci-dessus.In the context of the present invention, an additional active ingredient is an active ingredient other than component A) present in the composition and other active agents particularly defined above.
De manière avantageuse, un tel ingrédient actif supplémentaire, cosmétique, dermatologique ou pharmaceutique, peut être censé exercer un effet cosmétique, de soin ou d’hygiène sur des matières kératineuses telles que la peau, y compris le visage, les cheveux, les cils et/ou le cuir chevelu, et de préférence, la peau.Advantageously, such an additional active ingredient, cosmetic, dermatological or pharmaceutical, can be supposed to exert a cosmetic, care or hygiene effect on keratinous materials such as the skin, including the face, the hair, the eyelashes and / or the scalp, and preferably the skin.
Le choix de cet ingrédient actif supplémentaire est bien évidemment conditionné par l’effet recherché conjointement par la composition en question.The choice of this additional active ingredient is obviously conditioned by the effect jointly sought by the composition in question.
Ainsi, une composition selon l’invention peut comprendre en outre un ingrédient actif ayant une activité anti-âge ou une activité d’hydratation.Thus, a composition according to the invention may additionally comprise an active ingredient having an anti-aging activity or a moisturizing activity.
Bien évidemment, l’homme du métier veillera à choisir l’ingrédient ou les ingrédients actif(s) supplémentaire(s) optionnel(s) ajoutés à la composition selon l’invention de telle manière que les propriétés avantageuses liées intrinsèquement à la composition selon l’invention ne soient pas, ou sensiblement pas, altérées par l’addition proposée.Of course, those skilled in the art will take care to choose the optional additional active ingredient(s) added to the composition according to the invention in such a way that the advantageous properties intrinsically linked to the composition according to the invention are not, or substantially not, altered by the proposed addition.
Ces ingrédients actifs supplémentaires sont généralement présents dans la composition dans une teneur de 0,0001 % à 20 % en poids et de préférence, de 0,01 % à 10 % en poids par rapport au poids total de ladite composition.These additional active ingredients are generally present in the composition in a content of 0.0001% to 20% by weight and preferably from 0.01% to 10% by weight relative to the total weight of said composition.
Les compositions selon l’invention peuvent être fabriquées par des procédés connus, généralement utilisés dans le domaine cosmétique ou dermatologique.The compositions according to the invention can be manufactured by known methods, generally used in the cosmetic or dermatological field.
La composition selon l’invention trouve son application dans un grand nombre de traitements de matières kératineuses telles que la peau, le cuir chevelu ou les membranes muqueuses (lèvres), et plus particulièrement la peau, en particulier pour le soin de la peau, pour nourrir la peau, empêcher la perte d’eau transépidermique et/ou protéger la peau.The composition according to the invention finds its application in a large number of treatments for keratinous materials such as the skin, the scalp or the mucous membranes (lips), and more particularly the skin, in particular for the care of the skin, for nourish the skin, prevent transepidermal water loss and/or protect the skin.
Le sujet de l’invention est également un procédé pour prendre soin ou maquiller les matières kératineuses, comprenant l’application aux matières kératineuses d’une composition telle que définie plus haut.The subject of the invention is also a process for caring for or making up keratinous materials, comprising the application to the keratinous materials of a composition as defined above.
L’objet de la présente invention est en particulier un procédé pour traiter une peau sèche et/ou rugueuse, comprenant l’application à la peau d’une composition telle que définie plus haut.The object of the present invention is in particular a method for treating dry and/or rough skin, comprising the application to the skin of a composition as defined above.
L’objet de l’invention est en particulier un procédé pour traiter une peau mature, comprenant l’application à la peau d’une composition telle que définie plus haut.The object of the invention is in particular a method for treating mature skin, comprising the application to the skin of a composition as defined above.
L’invention concerne également l’utilisation d’une composition telle que définie plus haut, pour prendre soin ou maquiller des matières kératineuses.The invention also relates to the use of a composition as defined above, for caring for or making up keratinous materials.
Dans un mode de réalisation particulier, la composition est adaptée au traitement d’une peau sèche.In a particular embodiment, the composition is suitable for the treatment of dry skin.
Dans un mode de réalisation, la composition est adaptée au traitement d’une peau mature.In one embodiment, the composition is suitable for treating mature skin.
ExemplesExamples
Les exemples suivants de compositions selon l’invention sont donnés à titre d’illustration et sans limitation. Les composés sont indiqués par un nom chimique ou nom INCI.The following examples of compositions according to the invention are given by way of illustration and without limitation. Compounds are indicated by a chemical name or INCI name.
Les quantités/concentrations d’ingrédients dans les compositions/formules indiquées ci-après sont exprimées en % en poids, par rapport au poids total de chaque composition/formule, sauf indication contraire.The quantities/concentrations of ingredients in the compositions/formulas indicated below are expressed in % by weight, relative to the total weight of each composition/formula, unless otherwise indicated.
[Tableau 1][Table 1]
Compositions de l’exemple 1 de l’invention et des exemples comparatifs 1-2 ;
(% en poids)
(disponible chez GUILIN LAYN NATURAL INGREDIENTS)
(% in weight)
(available from GUILIN LAYN NATURAL INGREDIENTS)
Les procédures de préparation des compositions dans les exemples ci-dessus ont été présentées rapidement comme suit :The procedures for preparing the compositions in the examples above have been briefly presented as follows:
1). peser tous les ingrédients et les mélanger ;1). weigh all the ingredients and mix them;
2). agiter les ingrédients à une température de 80 ℃ jusqu’à ce qu’ils soient dissous ; et2). stir the ingredients at a temperature of 80℃ until dissolved; And
3). refroidir à température ambiante.3). cool to room temperature.
EvaluationAssessment
Evaluation de la stabilité des compositions.Evaluation of the stability of the compositions.
Les procédures d’évaluation de la stabilité de chaque composition ont été présentées rapidement comme suit :The procedures for evaluating the stability of each composition have been briefly presented as follows:
1) introduire les compositions de l’exemple 1 et de l’exemple comparatif 1 respectivement dans des flacons en verre de 60 ml et les placer respectivement à température ambiante, et à 4 ℃, 37 ℃ et 45 ℃ pendant 2 mois pour observer l’état à chaque température ;1) Pack the compositions of Example 1 and Comparative Example 1 respectively into 60ml glass vials and place them respectively at room temperature, and at 4℃, 37℃ and 45℃ for 2 months to observe the state at each temperature;
2) au bout de 2 mois, sortir les compositions pour qu’elles atteignent la température ambiante, et observer l’aspect, la couleur et l’odeur des compositions ; et2) after 2 months, take out the compositions so that they reach room temperature, and observe the appearance, color and smell of the compositions; And
3) mesurer les teneurs en actifs des compositions qui ont été placées à 45 ℃.3) Measure the active contents of the compositions which have been placed at 45℃.
[Tableau 2][Table 2]
Performance des compositions
CRISTAUX
CRISTAUX
CRISTAUX
CRISTAUX
CRYSTALS
CRYSTALS
CRYSTALS
CRYSTALS
On observe qu’au bout de deux mois, 100 % de l’acide férulique est conservé à la fois pour l’exemple 1 et l’exemple comparatif 1 : toutefois, en ce qui concerne l’acide ascorbique, jusqu’à 98,4 % de l’acide ascorbique a été conservé pour l’exemple 1 alors que seulement 80 % de l’acide ascorbique a été conservé pour l’exemple comparatif 1.It is observed that after two months, 100% of the ferulic acid is retained both for example 1 and comparative example 1: however, with regard to ascorbic acid, up to 98, 4% of the ascorbic acid was kept for Example 1 while only 80% of the ascorbic acid was kept for Comparative Example 1.
Claims (10)
A) au moins deux antioxydants bifonctionnels choisis parmi des composés contenant de l’hydroxyle acide, servant également au moins d’agents de blanchiment ; et
B) au moins deux polyols qui sont liquides à température ambiante, dans laquelle au moins un des polyols est un polyol en C2-C6 ayant 2 ou 3 groupes hydroxyle,
dans laquelle la composition est anhydre.Composition for taking care of keratinous materials, comprising, essentially consisting of, or consisting of the following components:
A) at least two bifunctional antioxidants selected from compounds containing hydroxy acid, also serving as at least bleaching agents; And
B) at least two polyols which are liquid at room temperature, wherein at least one of the polyols is a C2-C6 polyol having 2 or 3 hydroxyl groups,
wherein the composition is anhydrous.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IBPCT/CN2020/142048 | 2020-12-31 | ||
PCT/CN2020/142048 WO2022141375A1 (en) | 2020-12-31 | 2020-12-31 | Composition for caring for kertatin materials |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3118579A1 true FR3118579A1 (en) | 2022-07-08 |
FR3118579B1 FR3118579B1 (en) | 2024-04-19 |
Family
ID=82258803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR2101420A Active FR3118579B1 (en) | 2020-12-31 | 2021-02-15 | COMPOSITION FOR CARE OF KERATINOUS MATERIALS |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN116669688A (en) |
FR (1) | FR3118579B1 (en) |
WO (1) | WO2022141375A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101084862A (en) * | 2006-04-21 | 2007-12-12 | 莱雅公司 | Compositions containing a hydroxylated diphenylmethane compound |
US20100166897A1 (en) * | 2008-12-30 | 2010-07-01 | L'oreal | Combination of monosaccharides with antioxidants and use thereof |
FR2954144A1 (en) * | 2009-12-18 | 2011-06-24 | Oreal | USE OF A POLYMER AS ANTIOXIDANT AGENT |
ES2617137T3 (en) * | 2008-08-12 | 2017-06-15 | Elc Management Llc | Composite particles that have an antioxidant-based protective system, and topical compositions comprising the same |
US20180325804A1 (en) * | 2017-05-12 | 2018-11-15 | Shaklee Corporation | Topical muscadine formulation for cosmetic use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2737122B1 (en) * | 1995-07-25 | 1997-09-12 | Oreal | STABLE COMPOSITION CONTAINING ASCORBIC ACID |
JP2004203835A (en) * | 2002-12-26 | 2004-07-22 | Nisshin Kagaku Kk | Ferulic acid-containing composition |
US9072919B2 (en) * | 2012-10-12 | 2015-07-07 | L'oreal S.A. | Synergistic antioxidant cosmetic compositions containing at least one of baicalin and taxifolin, at least one of caffeine and nicotinamide, at least one of vitamin C and resveratrol and ferulic acid |
US10695278B2 (en) * | 2016-03-31 | 2020-06-30 | L'oreal | Photo-stabilized compositions and methods of use |
US10137072B2 (en) * | 2016-03-31 | 2018-11-27 | L'oreal | Methods and compositions for providing broad spectrum photo protection using antioxidants |
US10898420B2 (en) * | 2016-10-31 | 2021-01-26 | L'oreal | Compositions containing phenolic compounds having synergistic antioxidant benefits |
CN107638331A (en) * | 2017-08-31 | 2018-01-30 | 澳宝化妆品(惠州)有限公司 | A kind of maintenance skin barrier and the moisturizing emulsion for resisting free radical |
FR3088548B1 (en) * | 2018-11-15 | 2021-01-22 | Oreal | COMPOSITION CONSISTING OF A DERIVATIVE OF CINNAMIC ACID AND A NON-IONIC, NON-ASSOCIATIVE CELLULOSIC POLYMER |
-
2020
- 2020-12-31 CN CN202080108286.9A patent/CN116669688A/en active Pending
- 2020-12-31 WO PCT/CN2020/142048 patent/WO2022141375A1/en active Application Filing
-
2021
- 2021-02-15 FR FR2101420A patent/FR3118579B1/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101084862A (en) * | 2006-04-21 | 2007-12-12 | 莱雅公司 | Compositions containing a hydroxylated diphenylmethane compound |
ES2617137T3 (en) * | 2008-08-12 | 2017-06-15 | Elc Management Llc | Composite particles that have an antioxidant-based protective system, and topical compositions comprising the same |
US20100166897A1 (en) * | 2008-12-30 | 2010-07-01 | L'oreal | Combination of monosaccharides with antioxidants and use thereof |
FR2954144A1 (en) * | 2009-12-18 | 2011-06-24 | Oreal | USE OF A POLYMER AS ANTIOXIDANT AGENT |
US20180325804A1 (en) * | 2017-05-12 | 2018-11-15 | Shaklee Corporation | Topical muscadine formulation for cosmetic use |
Also Published As
Publication number | Publication date |
---|---|
FR3118579B1 (en) | 2024-04-19 |
WO2022141375A1 (en) | 2022-07-07 |
CN116669688A (en) | 2023-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR3029409A1 (en) | A CAPILLARY COLORING PROCESS USING AT LEAST ONE COLOR, AN ORGANIC TITANIUM SALT, AND A NON-CELLULOSIC POLYSACCHARIDE | |
KR102679528B1 (en) | Compositions for topical application comprising dimethyl isosorbide, a polyol, and a phenolic or polyphenolic antioxidant | |
CA3151698A1 (en) | Skin lightening composition | |
JP4685375B2 (en) | Topical skin preparation | |
EP1172090B1 (en) | Skin dyeing compositions comprising dihydroxyacetone and a flavylium salt non substituted in position 3 | |
FR3118579A1 (en) | COMPOSITION FOR CARE OF KERATINOUS MATERIALS | |
JP2006008537A (en) | External preparation for skin | |
KR101304677B1 (en) | A chestnut bur extracts and a cosmetic composition containing the chestnut bur extracts as an active ingredient | |
KR20240099320A (en) | Cosmetic composition containing a high dose of retinol | |
FR3019037A1 (en) | PROCESS FOR COLORING KERATIN FIBERS FROM ORTHODIPHENOLS, METAL SALTS, OXIDIZING AGENT AND BASIC COMPOUND | |
FR3132215A1 (en) | COSMETIC COMPOSITIONS INCLUDING HIGH QUANTITIES OF HYDROXYPROPYL TETRAHYDROPYRANTRIOL | |
FR3118580A1 (en) | COMPOSITION FOR THE CARE OF KERATINOUS MATERIALS | |
JP3940633B2 (en) | Topical skin preparation | |
FR3146066A1 (en) | DYE COMPOSITION FOR DYEING KERATIN FIBERS AND KIT COMPRISING SAME | |
FR3132217A1 (en) | COSMETIC COMPOSITIONS COMPRISING HIGH QUANTITIES OF TRIFLUOROMETHYLPHENYL VALYLGLYCINE | |
JP2003335628A (en) | Skin care preparation for external use | |
FR3131840A1 (en) | COMPOSITION COMPRISING A SOLUBILIZED POLYPHENOL | |
FR3132219A1 (en) | Cosmetic composition comprising high amounts of ceramide-NP | |
FR3132213A1 (en) | COSMETIC COMPOSITIONS COMPRISING HIGH QUANTITIES OF HYDROXYPROPYL TETRAHYDROPYRANTRIOL | |
FR3132218A1 (en) | COSMETIC COMPOSITIONS INCLUDING HIGH AMOUNTS OF RETINOL | |
FR3132214A1 (en) | COSMETIC COMPOSITIONS COMPRISING LARGE QUANTITIES OF HYDROXYPROPYL TETRAHYDROPYRANTRIOL | |
JP2003137727A (en) | Skin care preparation | |
WO2023120260A1 (en) | Composition comprising solubilized polyphenol | |
EP4452205A1 (en) | Composition comprising solubilized polyphenol | |
FR3111072A1 (en) | Hair coloring process using a lanthanide salt and a natural dye |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20220708 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |